KKR (NYSE: KKR) returns to Q1 profit as revenues rise in 2026
KKR & Co. Inc. reports first-quarter 2026 results showing higher revenue but lower overall profit. Total revenues rose to $4,317,983 thousand from $3,110,183 thousand a year earlier, driven by both asset management and insurance operations.
Net income attributable to KKR & Co. Inc. was $405,229 thousand, compared with a loss of $185,924 thousand in the prior-year quarter, with common stockholders’ net income of $364,799 thousand, or $0.41 basic and $0.38 diluted per share. However, consolidated net income declined to $277,505 thousand as more earnings were attributed to KKR & Co. Inc. rather than noncontrolling interests.
The insurance segment generated strong investment income but recorded net investment-related losses of $652,697 thousand, while the asset management and strategic holdings segment saw net losses from investment activities of $316,379 thousand after large unrealized declines. Comprehensive income attributable to KKR & Co. Inc. turned to a loss of $142,566 thousand, mainly due to $715,547 thousand of unrealized losses on available-for-sale securities.
Positive
- None.
Negative
- None.
Insights
Revenue grew and KKR’s own earnings improved, but investment losses and OCI dragged down overall performance.
KKR reported total revenues of $4,317,983 thousand for Q1 2026, up from $3,110,183 thousand. Asset management fees and insurance investment income supported the top line, while capital allocation-based income fell versus the prior year.
Consolidated net income dropped to $277,505 thousand from $684,498 thousand, yet net income attributable to KKR & Co. Inc. improved to $405,229 thousand as less profit was allocated to noncontrolling interests. Common EPS turned positive at $0.41 basic after a loss a year earlier.
Both the asset management and insurance segments posted sizeable investment-related losses, including $316,379 thousand of net losses from investment activities and $652,697 thousand of net investment-related losses in insurance. Unrealized declines on available-for-sale securities drove a comprehensive loss attributable to KKR of $142,566 thousand, highlighting sensitivity to market marks this quarter.
Key Figures
Key Terms
Fee Related Earnings (FRE) financial
market risk benefit liabilities financial
variable interest entities ("VIEs") financial
allowance for credit losses financial
loan-to-value ratio financial
funds withheld payable at interest financial
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |

(State or other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification Number) |
Title of each class | Trading symbol(s) | Name of each exchange on which registered |
4.625% Subordinated Notes due 2061 of KKR Group Finance Co. IX LLC | ||
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Page | ||
PART I — FINANCIAL INFORMATION | ||
Item 1. | Financial Statements | |
Unaudited Condensed Consolidated Financial Statements | ||
Condensed Consolidated Statements of Financial Condition (Unaudited) as of March 31, 2026 and December 31, 2025 | 7 | |
Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 11 | |
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 13 | |
Condensed Consolidated Statements of Changes in Equity (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 14 | |
Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 16 | |
Notes to Financial Statements (Unaudited) | 19 | |
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 91 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 149 |
Item 4. | Controls and Procedures | 150 |
PART II — OTHER INFORMATION | ||
Item 1. | Legal Proceedings | 151 |
Item 1A. | Risk Factors | 151 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 151 |
Item 3. | Defaults Upon Senior Securities | 152 |
Item 4. | Mine Safety Disclosures | 152 |
Item 5. | Other Information | 152 |
Item 6. | Exhibits | 153 |
SIGNATURES | 154 | |
Page No. | |
Condensed Consolidated Statements of Financial Condition (Unaudited) as of March 31, 2026 and December 31, 2025 | 7 |
Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 11 |
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 13 |
Condensed Consolidated Statements of Changes in Equity (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 14 |
Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2026 and 2025 | 16 |
Notes to Consolidated Financial Statements | 19 |
KKR & CO. INC. CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION (UNAUDITED) | |||
(Amounts in Thousands, Except Share and Per Share Data) | |||
March 31, 2026 | December 31, 2025 | ||
Assets | |||
Asset Management and Strategic Holdings | |||
Cash and Cash Equivalents | $ | $ | |
Restricted Cash and Cash Equivalents | |||
Investments | |||
Due from Affiliates | |||
Other Assets | |||
Insurance | |||
Cash and Cash Equivalents | $ | $ | |
Restricted Cash and Cash Equivalents | |||
Investments | |||
Reinsurance Recoverable | |||
Insurance Intangible Assets | |||
Other Assets | |||
Separate Account Assets | |||
Total Assets | $ | $ | |
Liabilities and Equity | |||
Asset Management and Strategic Holdings | |||
Debt Obligations | $ | $ | |
Due to Affiliates | |||
Accrued Expenses and Other Liabilities | |||
Insurance | |||
Policy Liabilities (market risk benefit liabilities: $ March 31, 2026 and December 31, 2025, respectively.) | $ | $ | |
Debt Obligations | |||
Funds Withheld Payable at Interest | |||
Accrued Expenses and Other Liabilities | |||
Reinsurance Liabilities | |||
Separate Account Liabilities | |||
Total Liabilities | |||
Commitments and Contingencies (See Note 24) | |||
Redeemable noncontrolling interests (See Note 23) | |||
KKR & CO. INC. CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION (UNAUDITED) (CONTINUED) | |||
(Amounts in Thousands, Except Share and Per Share Data) | |||
March 31, 2026 | December 31, 2025 | ||
Stockholders' Equity | |||
Series D Mandatory Convertible Preferred Stock, $ issued and outstanding as of March 31, 2026 and December 31, 2025. | |||
Series I Preferred Stock, $ outstanding as of March 31, 2026 and December 31, 2025. | |||
Common Stock, $ 2025, respectively. | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Accumulated Other Comprehensive Income (Loss) | ( | ( | |
Total KKR & Co. Inc. Stockholders' Equity | |||
Noncontrolling Interests (See Note 22) | |||
Total Equity | |||
Total Liabilities and Equity | $ | $ | |
March 31, 2026 | |||||||
Consolidated CFEs | Consolidated Funds and Other Investment Vehicles | Other VIEs | Total | ||||
Assets | |||||||
Asset Management and Strategic Holdings | |||||||
Cash and Cash Equivalents | $ | $ | $ | $ | |||
Restricted Cash and Cash Equivalents | |||||||
Investments | |||||||
Other Assets | |||||||
Insurance | |||||||
Cash and Cash Equivalents | |||||||
Investments | |||||||
Other Assets | |||||||
Total Assets | $ | $ | $ | $ | |||
Liabilities | |||||||
Asset Management and Strategic Holdings | |||||||
Debt Obligations | $ | $ | $ | $ | |||
Accrued Expenses and Other Liabilities | |||||||
Insurance | |||||||
Debt Obligations | |||||||
Accrued Expenses and Other Liabilities | |||||||
Total Liabilities | $ | $ | $ | $ | |||
December 31, 2025 | |||||||
Consolidated CFEs | Consolidated Funds and Other Investment Vehicles | Other VIEs | Total | ||||
Assets | |||||||
Asset Management and Strategic Holdings | |||||||
Cash and Cash Equivalents | $ | $ | $ | $ | |||
Restricted Cash and Cash Equivalents | |||||||
Investments | |||||||
Other Assets | |||||||
Insurance | |||||||
Cash and Cash Equivalents | |||||||
Investments | |||||||
Other Assets | |||||||
Total Assets | $ | $ | $ | $ | |||
Liabilities | |||||||
Asset Management and Strategic Holdings | |||||||
Debt Obligations | $ | $ | $ | $ | |||
Accrued Expenses and Other Liabilities | |||||||
Insurance | |||||||
Debt Obligations | |||||||
Accrued Expenses and Other Liabilities | |||||||
Total Liabilities | $ | $ | $ | $ | |||
KKR & CO. INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | |||
(Amounts in Thousands, Except Share and Per Share Data) | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Revenues | |||
Asset Management and Strategic Holdings | |||
Fees and Other | $ | $ | |
Capital Allocation-Based Income (Loss) | |||
Insurance | |||
Net Premiums | |||
Policy Fees | |||
Net Investment Income | |||
Net Investment-Related Gains (Losses) | ( | ( | |
Other Income | |||
Total Revenues | |||
Expenses | |||
Asset Management and Strategic Holdings | |||
Compensation and Benefits | |||
Occupancy and Related Charges | |||
General, Administrative and Other | |||
Insurance | |||
Net Policy Benefits and Claims (including market risk benefit (gain) loss of $ for the three months ended March 31, 2026 and 2025, respectively; remeasurement (gain) loss on policy liabilities: $ respectively.) | |||
Amortization of Policy Acquisition Costs | |||
Interest Expense | |||
Policy and Other Operating Expense | |||
Total Expenses | |||
Investment Income (Loss) - Asset Management and Strategic Holdings | |||
Net Gains (Losses) from Investment Activities | ( | ||
Dividend Income | |||
Interest Income | |||
Interest Expense | ( | ( | |
Total Investment Income (Loss) | |||
Income (Loss) Before Taxes | |||
KKR & CO. INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | |||
(Amounts in Thousands, Except Share and Per Share Data) | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Income Tax Expense (Benefit) | |||
Net Income (Loss) | |||
Net Income (Loss) Attributable to Redeemable Noncontrolling Interests | ( | ||
Net Income (Loss) Attributable to Noncontrolling Interests | ( | ||
Net Income (Loss) Attributable to KKR & Co. Inc. | ( | ||
Series D Mandatory Convertible Preferred Stock Dividends | |||
Net Income (Loss) Attributable to KKR & Co. Inc. Common Stockholders | $ | $( | |
Net Income (Loss) Attributable to KKR & Co. Inc. Per Share of Common Stock | |||
Basic | $ | $( | |
Diluted | $ | $( | |
Weighted Average Shares of Common Stock Outstanding | |||
Basic | |||
Diluted | |||
KKR & CO. INC. | ||||
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) | ||||
(Amounts in Thousands) | ||||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Net Income (Loss) | $ | $ | ||
Other Comprehensive Income (Loss), Net of Tax: | ||||
Unrealized Gains (Losses) on Available-For-Sale Securities and Other | ( | |||
Net effect of changes in discount rates and instrument-specific credit risk on policy liabilities | ( | |||
Foreign Currency Translation Adjustments | ( | |||
Comprehensive Income (Loss) | ( | |||
Comprehensive Income (Loss) Attributable to Redeemable Noncontrolling Interests | ( | |||
Comprehensive Income (Loss) Attributable to Noncontrolling Interests | ( | |||
Comprehensive Income (Loss) Attributable to KKR & Co. Inc. | $( | $ | ||
KKR & CO. INC. | |||
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) | |||
(Amounts in Thousands, Except Share and Per Share Data) | |||
Three Months Ended March 31, 2026 | |||
Amounts | Shares | ||
Series D Mandatory Convertible Preferred Stock | |||
Beginning of Period | $ | ||
End of Period | |||
Series I Preferred Stock | |||
Beginning of Period | — | ||
End of Period | — | ||
Common Stock | |||
Beginning of Period | |||
Net Delivery of Common Stock (Equity Incentive Plan) | — | ||
Repurchases of Common Stock | ( | ( | |
Exchange of KKR Restricted Holdings Units | |||
Private Placement Share Issuance | — | ||
End of Period | |||
Additional Paid-In Capital | |||
Beginning of Period | |||
Net Delivery of Common Stock (Equity Incentive Plan) | ( | ||
Repurchases of Common Stock | ( | ||
Equity-Based Compensation (Non-Cash Contribution) | |||
Change in KKR & Co. Inc.'s Ownership Interest (See Note 22) | |||
Tax Effects of Changes in Ownership and Other | ( | ||
End of Period | |||
Retained Earnings | |||
Beginning of Period | |||
Net Income (Loss) Attributable to KKR & Co. Inc. | |||
Series D Mandatory Convertible Preferred Stock Dividends ($ | ( | ||
Common Stock Dividends ($ | ( | ||
End of Period | |||
Accumulated Other Comprehensive Income (Loss) (net of tax) | |||
Beginning of Period | ( | ||
Other Comprehensive Income (Loss) | ( | ||
Change in KKR & Co. Inc.'s Ownership Interest (See Note 22) | |||
End of Period | ( | ||
Total KKR & Co. Inc. Stockholders' Equity | |||
Noncontrolling Interests (See Note 22) | |||
Total Equity | $ | ||
Redeemable Noncontrolling Interests (See Note 23) | $ | ||
KKR & CO. INC. | |||
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (CONTINUED) | |||
(Amounts in Thousands, Except Share and Per Share Data) | |||
Three Months Ended March 31, 2025 | |||
Amounts | Shares | ||
Series D Mandatory Convertible Preferred Stock | |||
Beginning of Period | $ | ||
Issuance of Series D Mandatory Convertible Preferred Stock (net of issuance costs) | |||
End of Period | |||
Series I Preferred Stock | |||
Beginning of Period | — | ||
End of Period | — | ||
Common Stock | |||
Beginning of Period | |||
Net Delivery of Common Stock (Equity Incentive Plan) | — | ||
Clawback of Transfer Restricted Shares | — | ( | |
Private Placement Share Issuance | — | ||
End of Period | |||
Additional Paid-In Capital | |||
Beginning of Period | |||
Net Delivery of Common Stock (Equity Incentive Plan) | ( | ||
Equity-Based Compensation (Non-Cash Contribution) | |||
Change in KKR & Co. Inc.'s Ownership Interest (See Note 22) | |||
Tax Effects of Changes in Ownership and Other | |||
End of Period | |||
Retained Earnings | |||
Beginning of Period | |||
Net Income (Loss) Attributable to KKR & Co. Inc. | ( | ||
Common Stock Dividends ($ | ( | ||
End of Period | |||
Accumulated Other Comprehensive Income (Loss) (net of tax) | |||
Beginning of Period | ( | ||
Other Comprehensive Income (Loss) | |||
Change in KKR & Co. Inc.'s Ownership Interest (See Note 22) | |||
End of Period | ( | ||
Total KKR & Co. Inc. Stockholders' Equity | |||
Noncontrolling Interests (See Note 22) | |||
Total Equity | $ | ||
Redeemable Noncontrolling Interests (See Note 23) | $ | ||
KKR & CO. INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | |||
(Amounts in Thousands) | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Operating Activities | |||
Net Income (Loss) | $ | $ | |
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities: | |||
Equity-Based Compensation | |||
Net Realized (Gains) Losses – Asset Management and Strategic Holdings | ( | ( | |
Change in Unrealized (Gains) Losses – Asset Management and Strategic Holdings | ( | ||
Capital Allocation-Based (Income) Loss – Asset Management and Strategic Holdings | ( | ( | |
Net Investment and Policy Liability-Related (Gains) Losses – Insurance | |||
Net Accretion and Amortization | ( | ( | |
Interest Credited to Policyholder Account Balances (net of Policy Fees) – Insurance | |||
Other Non-Cash Amounts | |||
Cash Flows Due to Changes in Operating Assets and Liabilities: | |||
Reinsurance Transactions and Acquisitions, Net of Cash Provided – Insurance | |||
Change in Premiums, Notes Receivable and Reinsurance Recoverable, Net of Reinsurance Premiums Payable – Insurance | |||
Change in Deferred Policy Acquisition Costs – Insurance | ( | ( | |
Change in Policy Liabilities and Accruals, Net – Insurance | ( | ||
Change in Consolidation | ( | ||
Change in Due from / to Affiliates | ( | ||
Change in Other Assets | |||
Change in Accrued Expenses and Other Liabilities | |||
Investments Purchased – Asset Management and Strategic Holdings | ( | ( | |
Proceeds from Investments – Asset Management and Strategic Holdings | |||
Net Cash Provided (Used) by Operating Activities | |||
Investing Activities | |||
Acquisitions, Net | ( | ||
Purchases of Fixed Assets | ( | ( | |
Investments Purchased – Insurance | ( | ( | |
Proceeds from Investments – Insurance | |||
Other Investing Activities, Net | ( | ||
Net Cash Provided (Used) by Investing Activities | ( | ||
KKR & CO. INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED) | |||
(Amounts in Thousands) | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Financing Activities | |||
Series D Mandatory Convertible Preferred Stock Dividends | ( | ||
Common Stock Dividends | ( | ( | |
Distributions to Redeemable Noncontrolling Interests | ( | ( | |
Contributions from Redeemable Noncontrolling Interests | |||
Distributions to Noncontrolling Interests | ( | ( | |
Contributions from Noncontrolling Interests | |||
Issuance of Series D Mandatory Convertible Preferred Stock (net of issuance costs) | |||
Net Delivery of Common Stock (Equity Incentive Plan) | ( | ( | |
Repurchases of Common Stock | ( | ||
Proceeds from Debt Obligations | |||
Repayment of Debt Obligations | ( | ( | |
Financing Costs Paid | ( | ( | |
Additions to Contractholder Deposit Funds – Insurance | |||
Withdrawals from Contractholder Deposit Funds – Insurance | ( | ( | |
Reinsurance Transactions, Net of Cash Provided – Insurance | |||
Other Financing Activity, Net | |||
Net Cash Provided (Used) by Financing Activities | ( | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ( | ||
Net Increase/(Decrease) in Cash, Cash Equivalents and Restricted Cash | $ | $ | |
Cash, Cash Equivalents and Restricted Cash, Beginning of Period | |||
Cash, Cash Equivalents and Restricted Cash, End of Period | $ | $ | |
Cash, Cash Equivalents and Restricted Cash are comprised of the following: | |||
Beginning of the Period | |||
Asset Management and Strategic Holdings | |||
Cash and Cash Equivalents | $ | $ | |
Restricted Cash and Cash Equivalents | |||
Total Asset Management and Strategic Holdings | |||
Insurance | |||
Cash and Cash Equivalents | $ | $ | |
Restricted Cash and Cash Equivalents | |||
Total Insurance | |||
Cash, Cash Equivalents and Restricted Cash, Beginning of Period | $ | $ | |
End of the Period | |||
Asset Management and Strategic Holdings | |||
Cash and Cash Equivalents | $ | $ | |
Restricted Cash and Cash Equivalents | |||
Total Asset Management and Strategic Holdings | |||
Insurance | |||
Cash and Cash Equivalents | $ | $ | |
Restricted Cash and Cash Equivalents | |||
Total Insurance | |||
Cash, Cash Equivalents and Restricted Cash, End of Period | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Supplemental Disclosures of Cash Flow Information | |||
Payments for Interest | $ | $ | |
Payments for Income Taxes, Net of Refunds | $ | $ | |
Payments for Operating Lease Liabilities | $ | $ | |
Supplemental Disclosures of Non-Cash Investing and Financing Activities | |||
Non-Cash Contribution from Noncontrolling Interests | $ | $ | |
Non-Cash Distribution to Noncontrolling Interests | $( | $ | |
Non-Cash Distribution to Redeemable Noncontrolling Interests | $( | $ | |
Non-Cash Repayment of Debt Obligations | $ | $( | |
Debt Obligations – Net Gains (Losses), Translation and Other | $ | $ | |
Contractholder Deposit Funds Acquired through Reinsurance Agreements | $ | $ | |
Change in Consolidation | |||
Investments – Asset Management and Strategic Holdings | $ | $ | |
Other Assets | $ | $( | |
Accrued Expenses and Other Liabilities | $ | $( | |
Noncontrolling Interests | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Management Fees | $ | $ | |
Fee Credits | ( | ( | |
Transaction Fees | |||
Monitoring Fees | |||
Incentive Fees | |||
Expense Reimbursements | |||
Consulting Fees | |||
Total Fees and Other | |||
Carried Interest | |||
General Partner Capital Interest | |||
Total Capital Allocation-Based Income (Loss) | |||
Total Revenues | $ | $ | |
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | ||||||||||
Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Total | Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Total | ||||||
Private Equity (1) | $ | $( | $( | $ | $ | $ | |||||
Credit (1) | ( | ( | ( | ( | ( | ||||||
Investments of Consolidated CFEs (1) | ( | ( | ( | ( | ( | ( | |||||
Real Assets (1) | ( | ||||||||||
Other Investments (1) | ( | ||||||||||
Foreign Exchange Forward Contracts and Options (2) | ( | ( | ( | ||||||||
Securities Sold Short (2) | ( | ( | |||||||||
Other Derivatives (2) | ( | ( | ( | ( | ( | ||||||
Debt Obligations and Other (3) | |||||||||||
Net Gains (Losses) From Investment Activities (4) | $ | $( | $( | $ | $ | $ | |||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Fixed Maturity Securities | $ | $ | |
Mortgage and Other Loan Receivables | |||
Real Assets | |||
Short-Term and Other Investment Income | |||
Income Assumed from Funds Withheld Receivable at Interest | |||
Policy Loans | |||
Income Ceded to Funds Withheld Payable at Interest | ( | ( | |
Total Investment Income (Losses) | |||
Less Investment Expenses: | |||
Investment Management and Administration | |||
Real Asset Depreciation and Maintenance | |||
Interest Expense on Derivative Collateral and Repurchase Agreements | |||
Net Investment Income | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Realized Gains (Losses) on Available-For-Sale Fixed Maturity Securities | $( | $( | |
Credit Loss Allowances on Available-For-Sale Securities | ( | ( | |
Credit Loss Allowances on Mortgage and Other Loan Receivables | ( | ( | |
Credit Loss Allowances on Unfunded Commitments | |||
Unrealized Gains (Losses) on Fixed Maturity Securities Classified as Trading | ( | ||
Unrealized Gains (Losses) on Other Investments Recognized Under the Fair-Value Option and Equity Investments | ( | ||
Unrealized Gains (Losses) on Real Assets | ( | ||
Realized Gains on Real Assets | |||
Net Gains (Losses) on Derivative Instruments | ( | ( | |
Realized Gains (Losses) on Funds Withheld at Interest Payable Portfolio | |||
Realized Gains (Losses) on Funds Withheld at Interest Receivable Portfolio | ( | ( | |
Foreign Exchange Gains (Losses) on Non-USD Denominated Investments | ( | ||
Other Realized Gains (Losses) | ( | ||
Net Investment-Related Gains (Losses) | $( | $( | |
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | ||||||||||
Corporate | Structured | Total | Corporate | Structured | Total | ||||||
Balance, as of Beginning of Period | $ | $ | $ | $ | $ | $ | |||||
Initial Credit Loss Allowance Recognized on Securities with No Previously Recognized Allowance | |||||||||||
Accretion of Initial Credit Loss Allowance on PCD Securities | |||||||||||
Reductions Due to Sales (or Maturities, Pay Downs or Prepayments) During the Period of Securities with a Previously Recognized Credit Loss Allowance | ( | ( | ( | ( | ( | ( | |||||
Net Additions / Reductions for Securities with a Previously Recognized Credit Loss Allowance | ( | ||||||||||
Balances Charged Off | ( | ( | ( | ( | |||||||
Balance, as of End of Period | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | ||||||||||||||
Commercial Mortgage Loans | Residential Mortgage Loans | Consumer and Other Loan Receivables | Total | Commercial Mortgage Loans | Residential Mortgage Loans | Consumer and Other Loan Receivables | Total | ||||||||
Balance, as of Beginning of Period | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Net Provision (Release) | |||||||||||||||
Charge-Offs | ( | ( | ( | ( | ( | ( | ( | ||||||||
Recoveries of Amounts Previously Charged-Off | |||||||||||||||
Balance, as of End of Period | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
AFS Fixed Maturity Securities: | |||
Proceeds from Voluntary Sales | $ | $ | |
Gross Gains | $ | $ | |
Gross Losses | $( | $( | |
March 31, 2026 | December 31, 2025 | ||
Asset Management and Strategic Holdings | |||
Private Equity | $ | $ | |
Credit | |||
Investments of Consolidated CFEs | |||
Real Assets | |||
Equity Method - Capital Allocation-Based Income | |||
Other Investments | |||
Investments – Asset Management and Strategic Holdings (7) | $ | $ | |
Insurance | |||
Fixed Maturity Securities, Available-For-Sale, at Fair Value(1) | $ | $ | |
Mortgage and Other Loan Receivables | |||
Fixed Maturity Securities, Trading, at Fair Value(2) | |||
Real Assets(3)(4) | |||
Other Investments(4)(5) | |||
Funds Withheld Receivable at Interest | |||
Policy Loans | |||
Investments – Insurance(6) | $ | $ | |
Total Investments | $ | $ |
Cost or Amortized Cost | Allowance for Credit Losses (1)(2) | Gross Unrealized | Fair Value | ||||||
As of March 31, 2026 | Gains | Losses | |||||||
AFS Fixed Maturity Securities Portfolio by Type: | |||||||||
U.S. Government and Agencies | $ | $ | $ | $( | $ | ||||
U.S. State, Municipal and Political Subdivisions | ( | ||||||||
Corporate | ( | ( | |||||||
Residential Mortgage-Backed Securities, or “RMBS” | ( | ( | |||||||
Commercial Mortgage-Backed Securities, or “CMBS” | ( | ( | |||||||
CLOs | ( | ( | |||||||
Asset-Backed Securities, or “ABSs” | ( | ( | |||||||
Total AFS Fixed Maturity Securities | $ | $( | $ | $( | $ | ||||
Cost or Amortized Cost | Allowance for Credit Losses (1)(2) | Gross Unrealized | Fair Value | ||||||
As of December 31, 2025 | Gains | Losses | |||||||
AFS Fixed Maturity Securities Portfolio by Type: | |||||||||
U.S. Government and Agencies | $ | $ | $ | $( | $ | ||||
U.S. State, Municipal and Political Subdivisions | ( | ||||||||
Corporate | ( | ( | |||||||
RMBS | ( | ( | |||||||
CMBS | ( | ( | |||||||
CLOs | ( | ( | |||||||
ABSs | ( | ( | |||||||
Total AFS Fixed Maturity Securities | $ | $( | $ | $( | $ | ||||
As of March 31, 2026 | Cost or Amortized Cost (Net of Allowance) | Fair Value | |
Due in One Year or Less | $ | $ | |
Due After One Year Through Five Years | |||
Due After Five Years Through Ten Years | |||
Due After Ten Years | |||
Subtotal | |||
RMBS | |||
CMBS | |||
CLOs | |||
ABSs and other structured securities | |||
Total AFS Fixed Maturity Securities | $ | $ |
Less Than 12 Months | 12 Months or More | Total | ||||||||||
As of March 31, 2026 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | ||||||
AFS Fixed Maturity Securities Portfolio by Type: | ||||||||||||
U.S. Government and Agencies | $ | $( | $ | $( | $ | $( | ||||||
U.S. State, Municipal and Political Subdivisions | ( | ( | ( | |||||||||
Corporate | ( | ( | ( | |||||||||
RMBS | ( | ( | ( | |||||||||
CMBS | ( | ( | ( | |||||||||
CLOs | ( | ( | ( | |||||||||
ABSs | ( | ( | ( | |||||||||
Total AFS Fixed Maturity Securities in a Continuous Loss Position | $ | $( | $ | $( | $ | $( | ||||||
Less Than 12 Months | 12 Months or More | Total | ||||||||||
As of December 31, 2025 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | ||||||
AFS Fixed Maturity Securities Portfolio by Type: | ||||||||||||
U.S. Government and Agencies | $ | $( | $ | $( | $ | $( | ||||||
U.S. State, Municipal and Political Subdivisions | ( | ( | ( | |||||||||
Corporate | ( | ( | ( | |||||||||
RMBS | ( | ( | ( | |||||||||
CMBS | ( | ( | ( | |||||||||
CLOs | ( | ( | ( | |||||||||
ABSs | ( | ( | ( | |||||||||
Total AFS Fixed Maturity Securities in a Continuous Loss Position | $ | $( | $ | $( | $ | $( | ||||||
March 31, 2026 | December 31, 2025 | ||
Commercial Mortgage Loans(1) | $ | $ | |
Residential Mortgage Loans(1) | |||
Consumer Loans(1) | |||
Other Loan Receivables(1)(2) | |||
Total Mortgage and Other Loan Receivables | $ | $ | |
Allowance for Credit Losses(3) | ( | ( | |
Total Mortgage and Other Loan Receivables, Net of Allowance for Credit Losses | $ | $ |
Years | Residential | Commercial | Total Mortgage Loans | ||
Remainder of 2026 | $ | $ | $ | ||
2027 | |||||
2028 | |||||
2029 | |||||
2030 | |||||
2031 | |||||
Thereafter | |||||
Total | $ | $ | $ |
Mortgage Loans – Carrying Value by Geographic Region | March 31, 2026 | December 31, 2025 | |||||
South Atlantic | $ | $ | |||||
Pacific | |||||||
Middle Atlantic | |||||||
West South Central | |||||||
Mountain | |||||||
New England | |||||||
East North Central | |||||||
East South Central | |||||||
West North Central | |||||||
International | |||||||
Other Regions | |||||||
Total by Geographic Region | $ | $ | |||||
Mortgage Loans – Carrying Value by Property Type | March 31, 2026 | December 31, 2025 | |||||
Residential | $ | $ | |||||
Multi-Family | |||||||
Industrial | |||||||
Office Building | |||||||
Other Property Types | |||||||
Retail | |||||||
Warehouse | |||||||
Total by Property Type | $ | $ | |||||
By Year of Origination | ||||||||||||||
Performance Status as of March 31, 2026 | 2026 | 2025 | 2024 | 2023 | 2022 | Prior | Total | |||||||
Commercial Mortgage Loans | ||||||||||||||
Gross Charge-Offs for the Three Months Ended March 31, 2026 | $ | $ | $ | $ | $ | $( | $( | |||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30 to 59 Days Past Due | ||||||||||||||
60 to 89 Days Past Due | ||||||||||||||
90 Days or More Past Due or in Process of Foreclosure | ||||||||||||||
Total Commercial Mortgage Loans | $ | $ | $ | $ | $ | $ | $ | |||||||
Residential Mortgage Loans | ||||||||||||||
Gross Charge-Offs for the Three Months Ended March 31, 2026 | $ | $( | $( | $( | $( | $( | $( | |||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30 to 59 Days Past Due | ||||||||||||||
60 to 89 Days Past Due | ||||||||||||||
90 Days or More Past Due or in Process of Foreclosure | ||||||||||||||
Total Residential Mortgage Loans | $ | $ | $ | $ | $ | $ | $ | |||||||
Consumer Loans | ||||||||||||||
Gross Charge-Offs for the Three Months Ended March 31, 2026 | $ | $( | $( | $( | $( | $( | $( | |||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30 to 59 Days Past Due | ||||||||||||||
60 to 89 Days Past Due | ||||||||||||||
90 Days or More Past Due or in Process of Foreclosure | ||||||||||||||
Total Consumer Loans | $ | $ | $ | $ | $ | $ | $ | |||||||
Total Mortgage and Consumer Loan Receivables | $ | $ | $ | $ | $ | $ | $ | |||||||
By Year of Origination | ||||||||||||||
Performance Status as of December 31, 2025 | 2025 | 2024 | 2023 | 2022 | 2021 | Prior | Total | |||||||
Commercial Mortgage Loans | ||||||||||||||
Gross Charge-Offs for the Twelve Months Ended December 31, 2025 | $ | $ | $ | $ | $( | $( | $( | |||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30 to 59 Days Past Due | ||||||||||||||
60 to 89 Days Past Due | ||||||||||||||
90 Days or More Past Due or in Process of Foreclosure | ||||||||||||||
Total Commercial Mortgage Loans | $ | $ | $ | $ | $ | $ | $ | |||||||
Residential Mortgage Loans | ||||||||||||||
Gross Charge-Offs for the Twelve Months Ended December 31, 2025 | $ | $( | $( | $( | $( | $( | $( | |||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30 to 59 Days Past Due | ||||||||||||||
60 to 89 Days Past Due | ||||||||||||||
90 Days or More Past Due or in Process of Foreclosure | ||||||||||||||
Total Residential Mortgage Loans | $ | $ | $ | $ | $ | $ | $ | |||||||
Consumer Loans | ||||||||||||||
Gross Charge-Offs for the Twelve Months Ended December 31, 2025 | $( | $( | $( | $( | $( | $( | $( | |||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30 to 59 Days Past Due | ||||||||||||||
60 to 89 Days Past Due | ||||||||||||||
90 Days or More Past Due or in Process of Foreclosure | ||||||||||||||
Total Consumer Loans | $ | $ | $ | $ | $ | $ | $ | |||||||
Total Mortgage and Consumer Loan Receivables | $ | $ | $ | $ | $ | $ | $ | |||||||
Loan-to-Value as of March 31, 2026, by Year of Origination | Carrying Value Loan-to-Value 70% and Less | Carrying Value Loan-to-Value 71% - 90% | Carrying Value Loan-to-Value Over 90% | Total Carrying Value | ||||
2026 | $ | $ | $ | $ | ||||
2025 | ||||||||
2024 | ||||||||
2023 | ||||||||
2022 | ||||||||
2021 | ||||||||
Prior | ||||||||
Total Commercial Mortgage Loans | $ | $ | $ | $ |
Loan-to-Value as of December 31, 2025, by Year of Origination | Carrying Value Loan-to-Value 70% and Less | Carrying Value Loan-to-Value 71% - 90% | Carrying Value Loan-to-Value Over 90% | Total Carrying Value | ||||
2025 | $ | $ | $ | $ | ||||
2024 | ||||||||
2023 | ||||||||
2022 | ||||||||
2021 | ||||||||
2020 | ||||||||
Prior | ||||||||
Total Commercial Mortgage Loans | $ | $ | $ | $ |
Three Months Ended March 31, 2026 by Loan Type | Deferral of Amounts Due | Interest Rate Relief | Maturity Extension | Combination(1) | Total | Percentage of Total Carrying Value Outstanding | |||||
Commercial Mortgage Loans | $ | $ | $ | $ | $ | ||||||
Residential Mortgage Loans | |||||||||||
Consumer Loans | |||||||||||
Total(2) | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2025 by Loan Type | Deferral of Amounts Due | Interest Rate Relief | Maturity Extension | Combination(1) | Total | Percentage of Total Carrying Value Outstanding | |||||
Commercial Mortgage Loans | $ | $ | $ | $ | $ | ||||||
Residential Mortgage Loans | |||||||||||
Consumer Loans | |||||||||||
Total(2) | $ | $ | $ | $ | $ |
Performance Status as of March 31, 2026 by Loan Type | Current | 30-59 Days Past Due | 60-89 Days Past Due | 90 Days or More Past Due or in Process of Foreclosure | Total | ||||
Commercial Mortgage Loans | $ | $ | $ | $ | $ | ||||
Residential Mortgage Loans | |||||||||
Consumer Loans | |||||||||
Total(1) | $ | $ | $— | $ | 0 | $ | $ |
As of March 31, 2026 | Overnight | <30 Days | 30 - 90 Days | > 90 Days | Total | ||||
Residential Mortgage Loans | $ | $ | $ | $ | $ | ||||
Total Assets Pledged | $ | $ | $ | $ | $ |
As of December 31, 2025 | Overnight | <30 Days | 30 - 90 Days | > 90 Days | Total | ||||
Residential Mortgage Loans | $ | $ | $ | $ | $ | ||||
Total Assets Pledged | $ | $ | $ | $ | $ |
As of March 31, 2026 | A s o f | Notional Value | Derivative Assets | Derivative Liabilities | ||
Asset Management and Strategic Holdings | ||||||
Foreign Exchange Contracts and Options | $ | $ | $ | |||
Other Derivatives | ||||||
Total Asset Management and Strategic Holdings | $ | $ | $ | |||
Insurance | ||||||
Derivatives Designated as Hedge Accounting Instruments: | ||||||
Interest Rate Contracts | $ | $ | $ | |||
Foreign Currency Contracts | ||||||
Total Derivatives Designated as Hedge Accounting Instruments | $ | $ | $ | |||
Derivatives Not Designated as Hedge Accounting Instruments: | ||||||
Equity Market Contracts | $ | $ | $ | |||
Interest Rate Contracts | ||||||
Foreign Currency Contracts | ||||||
Other Contracts | ||||||
Total Derivatives Not Designated as Hedge Accounting Instruments | ||||||
Counterparty Netting(2) | — | ( | ( | |||
Cash Collateral | — | ( | ( | |||
Total Insurance(1) | $ | $ | $ | |||
Fair Value Included Within Total Assets and Liabilities | $ | $ | $ |
As of December 31, 2025 | Notional Value | Derivative Assets | Derivative Liabilities | |||
Asset Management and Strategic Holdings | ||||||
Foreign Exchange Contracts and Options | $ | $ | $ | |||
Other Derivatives | ||||||
Total Asset Management and Strategic Holdings | $ | $ | $ | |||
Insurance | ||||||
Derivatives Designated as Hedge Accounting Instruments: | ||||||
Interest Rate Contracts | $ | $ | $ | |||
Foreign Currency Contracts | ||||||
Total Derivatives Designated as Hedge Accounting Instruments | $ | $ | $ | |||
Derivatives Not Designated as Hedge Accounting Instruments: | ||||||
Equity Market Contracts | $ | $ | $ | |||
Interest Rate Contracts | ||||||
Foreign Currency Contracts | ||||||
Other Contracts | ||||||
Total Derivatives Not Designated as Hedge Accounting Instruments | ||||||
Counterparty Netting(2) | — | ( | ( | |||
Cash Collateral | — | ( | ( | |||
Total Insurance(1) | $ | $ | $ | |||
Fair Value Included Within Total Assets and Liabilities | $ | $ | $ |
As of March 31, 2026 | As of December 31, 2025 | ||||||
Carrying Amount of Hedged Liabilities | Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Liabilities(1) | Carrying Amount of Hedged Liabilities | Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Liabilities(1) | ||||
Debt | $ | $( | $ | $( | |||
Policy Liabilities | ( | ( | |||||
Three Months Ended March 31, 2026 | |||||||||
Net Investment- Related Gains (Losses) | Net Investment Income | Net Policy Benefits and Claims | Interest Expense | Change in AOCI | |||||
Derivatives Designated as Hedge Accounting Instruments: | |||||||||
Fair Value Hedges | |||||||||
Gains (Losses) on Derivatives Designated as Hedge Instruments: | |||||||||
Interest Rate Contracts | $— | $— | $( | $( | $— | ||||
Foreign Currency Contracts | ( | — | ( | ||||||
Total Gains (Losses) on Derivatives Designated as Hedge Instruments | $ | $ | $( | $( | $( | ||||
Gains (Losses) on Hedged Items: | |||||||||
Interest Rate Contracts | $— | $— | $ | $ | $— | ||||
Foreign Currency Contracts | ( | — | — | — | |||||
Total Gains (Losses) on Hedged Items | $( | $— | $ | $ | $— | ||||
Amortization for Gains (Losses) Excluded from Assessment of Effectiveness: | |||||||||
Foreign Currency Contracts | $ | $— | $— | $— | $— | ||||
Total Amortization for Gains (Losses) Excluded from Assessment of Effectiveness | $ | $— | $— | $— | $— | ||||
Total Gains (Losses) on Fair Value Hedges, Net of Hedged Items | $ | $ | $— | $— | $( | ||||
Cash Flow Hedges | |||||||||
Foreign Currency Contracts | $— | $— | $( | $— | $( | ||||
Interest Rate Contracts | ( | — | — | ( | |||||
Total Gains (Losses) on Cash Flow Hedges | $ | $( | $( | $— | $( | ||||
Net Investment Hedges | |||||||||
Gains (Losses) on Derivatives Designated as Hedge Instruments | $ | $ | $— | $— | $ | ||||
Total Gains (Losses) on Net Investment Hedges | $ | $ | $— | $— | $ | ||||
Derivatives Not Designated as Hedge Accounting Instruments: | |||||||||
Insurance | |||||||||
Embedded Derivatives - Funds Withheld Receivable | $( | $— | $— | $— | $— | ||||
Embedded Derivatives - Funds Withheld Payable | — | — | — | — | |||||
Equity Index Options | ( | — | — | — | — | ||||
Equity Futures Contracts | — | — | — | — | |||||
Interest Rate Contracts | ( | — | — | — | — | ||||
Credit risk contracts | |||||||||
Foreign Exchange and Other Derivative Contracts | — | — | — | — | |||||
Total Gains (Losses) on Derivatives Not Designated as Hedge Accounting Instruments from Insurance Activities | $( | $— | $— | $— | $— | ||||
Total | $( | $( | $( | $— | $( | ||||
Three Months Ended March 31, 2025 | |||||||||
Net Investment- Related Gains (Losses) | Net Investment Income | Net Policy Benefits and Claims | Interest Expense | Change in AOCI | |||||
Derivatives Designated as Hedge Accounting Instruments: | |||||||||
Fair Value Hedges | |||||||||
Gains (Losses) on Derivatives Designated as Hedge Instruments: | |||||||||
Interest Rate Contracts | $— | $— | $ | $ | $— | ||||
Foreign Currency Contracts | ( | — | — | ||||||
Total Gains (Losses) on Derivatives Designated as Hedge Instruments | $( | $ | $ | $ | $ | ||||
Gains (Losses) on Hedged Items: | |||||||||
Interest Rate Contracts | $— | $— | $( | $( | $— | ||||
Foreign Currency Contracts | — | — | — | — | |||||
Total Gains (Losses) on Hedged Items | $ | $— | $( | $( | $— | ||||
Amortization for Gains (Losses) Excluded from Assessment of Effectiveness: | |||||||||
Foreign Currency Contracts | $ | $— | $— | $— | $— | ||||
Total Amortization for Gains (Losses) Excluded from Assessment of Effectiveness | $ | $— | $— | $— | $— | ||||
Total Gains (Losses) on Fair Value Hedges, Net of Hedged Items | $( | $ | $— | $— | $ | ||||
Cash Flow Hedges | |||||||||
Interest Rate Contracts | $ | $( | $— | $— | $ | ||||
Total Gains (Losses) on Cash Flow Hedges | $ | $( | $— | $— | $ | ||||
Net Investment Hedges | |||||||||
Gains (Losses) on Derivatives Designated as Hedge Instruments | $ | $ | $— | $— | $ | ||||
Total Gains (Losses) on Net Investment Hedges | $ | $ | $— | $— | $ | ||||
Derivatives Not Designated as Hedge Accounting Instruments: | |||||||||
Insurance | |||||||||
Embedded Derivatives - Funds Withheld Receivable | $( | $— | $— | $— | $— | ||||
Embedded Derivatives - Funds Withheld Payable | ( | — | — | — | — | ||||
Equity Index Options | ( | — | — | — | — | ||||
Equity Futures Contracts | — | — | — | — | |||||
Interest Rate Contracts | — | — | — | — | |||||
Foreign Exchange and Other Derivative Contracts | ( | — | — | — | — | ||||
Total Gains (Losses) on Derivatives Not Designated as Hedge Accounting Instruments from Insurance Activities | $( | $— | $— | $— | $— | ||||
Total | $( | $ | $ | $— | $ | ||||
As of March 31, 2026 | Gross Amount Recognized | Gross Amounts Offset in the Statements of Financial Condition(1) | Net Amounts Presented in the Statements of Financial Condition | Collateral (Received) / Pledged | Net Amount After Collateral | ||||
Derivative Assets (Excluding Embedded Derivatives) | $ | $( | $ | $( | $ | ||||
Derivative Liabilities (Excluding Embedded Derivatives) | $ | $( | $ | $ | $( |
As of December 31, 2025 | Gross Amount Recognized | Gross Amounts Offset in the Statements of Financial Condition(1) | Net Amounts Presented in the Statements of Financial Condition | Collateral (Received) / Pledged | Net Amount After Collateral | ||||
Derivative Assets (Excluding Embedded Derivatives) | $ | $( | $ | $( | $( | ||||
Derivative Liabilities (Excluding Embedded Derivatives) | $ | $( | $ | $ | $( |
March 31, 2026 | |||||||
Level I | Level II | Level III | Total | ||||
Asset Management and Strategic Holdings | |||||||
Private Equity | $ | $ | $ | $ | |||
Credit | |||||||
Investments of Consolidated CFEs | |||||||
Real Assets | |||||||
Other Investments | |||||||
Total Investments (2)(3) | $ | $ | $ | $ | |||
Foreign Exchange Contracts and Options | |||||||
Other Derivatives | |||||||
Total Assets at Fair Value – Asset Management and Strategic Holdings | $ | $ | $ | $ | |||
Insurance | |||||||
AFS Fixed Maturity Securities: | |||||||
U.S. Government and Agencies | $ | $ | $ | $ | |||
U.S. State, Municipal and Political Subdivisions | |||||||
Corporate | |||||||
Structured Securities | |||||||
Total AFS Fixed Maturity Securities | $ | $ | $ | $ | |||
Trading Fixed Maturity Securities | $ | $ | $ | $ | |||
Mortgage and Other Loan Receivables | |||||||
Real Assets | (1) | ||||||
Other Investments | (1) | ||||||
Funds Withheld Receivable at Interest | |||||||
Reinsurance Recoverable | |||||||
Derivative Assets (4) | |||||||
Separate Account Assets | |||||||
Total Assets at Fair Value – Insurance | $ | $ | $ | $ | |||
Total Assets at Fair Value | $ | $ | $ | $ | |||
December 31, 2025 | |||||||
Level I | Level II | Level III | Total | ||||
Asset Management and Strategic Holdings | |||||||
Private Equity | $ | $ | $ | $ | |||
Credit | |||||||
Investments of Consolidated CFEs | |||||||
Real Assets | |||||||
Other Investments | |||||||
Total Investments (3) | $ | $ | $ | $ | |||
Foreign Exchange Contracts and Options | |||||||
Other Derivatives | |||||||
Total Assets at Fair Value – Asset Management and Strategic Holdings | $ | $ | $ | $ | |||
Insurance | |||||||
AFS Fixed Maturity Securities: | |||||||
U.S. Government and Agencies | $ | $ | $ | $ | |||
U.S. State, Municipal and Political Subdivisions | |||||||
Corporate | |||||||
Structured Securities | |||||||
Total AFS Fixed Maturity Securities | $ | $ | $ | $ | |||
Trading Fixed Maturity Securities | $ | $ | $ | $ | |||
Mortgage and Other Loan Receivables | |||||||
Real Assets | '(1) | ||||||
Other Investments | '(1) | ||||||
Funds Withheld Receivable at Interest | |||||||
Reinsurance Recoverable | |||||||
Derivative Assets (4) | $ | $ | $ | $ | |||
Separate Account Assets | |||||||
Total Assets at Fair Value – Insurance | $ | $ | $ | $ | |||
Total Assets at Fair Value | $ | $ | $ | $ | |||
March 31, 2026 | |||||||
Level I | Level II | Level III | Total | ||||
Asset Management and Strategic Holdings | |||||||
Securities Sold Short | $ | $ | $ | $ | |||
Foreign Exchange Contracts and Options | |||||||
Unfunded Revolver Commitments | (1) | ||||||
Other Derivatives | |||||||
Debt Obligations of Consolidated CFEs | |||||||
Total Liabilities at Fair Value – Asset Management and Strategic Holdings | $ | $ | $ | $ | |||
Insurance | |||||||
Policy Liabilities (Including Market Risk Benefits) | $ | $ | $ | (3) | $ | ||
Closed Block Policy Liabilities | |||||||
Funds Withheld Payable at Interest | ( | ( | |||||
Derivative Instruments Payable (2) | |||||||
Embedded Derivative – Interest-Sensitive Life Products | |||||||
Embedded Derivative – Annuity Products | |||||||
Total Liabilities at Fair Value – Insurance | $ | $ | $ | $ | |||
Total Liabilities at Fair Value | $ | $ | $ | $ | |||
December 31, 2025 | |||||||
Level I | Level II | Level III | Total | ||||
Asset Management and Strategic Holdings | |||||||
Securities Sold Short | $ | $ | $ | $ | |||
Foreign Exchange Contracts and Options | |||||||
Unfunded Revolver Commitments | (1) | ||||||
Debt Obligations of Consolidated CFEs | |||||||
Total Liabilities at Fair Value – Asset Management and Strategic Holdings | $ | $ | $ | $ | |||
Insurance | |||||||
Policy Liabilities (Including Market Risk Benefits) | $ | $ | $ | (3) | $ | ||
Closed Block Policy Liabilities | |||||||
Funds Withheld Payable at Interest | ( | ( | |||||
Derivative Instruments Payable (2) | |||||||
Embedded Derivative – Interest-Sensitive Life Products | |||||||
Embedded Derivative – Annuity Products | |||||||
Total Liabilities at Fair Value – Insurance | $ | $ | $ | $ | |||
Total Liabilities at Fair Value | $ | $ | $ | $ | |||
Three Months Ended March 31, 2026 | ||||||||||
Balance, Beg. of Period | Transfers In / (Out) - Changes in Consolidation | Transfers In | Transfers Out | Net Purchases/ Issuances/ Sales/ Settlements | Net Unrealized and Realized Gains (Losses) | Change in OCI | Balance, End of Period | Changes in Net Unrealized Gains (Losses) Included in Earnings related to Level III Assets and Liabilities still held as of the Reporting Date | Changes in Net Unrealized Gains (Losses) Included in OCI related to Level III Assets and Liabilities still held as of the Reporting Date | |
Assets (1) | ||||||||||
Asset Management and Strategic Holdings | ||||||||||
Private Equity | $ | $ | $ | $( | $ | $( | $ | $ | $( | $ |
Credit | ( | ( | ||||||||
Real Assets | ( | |||||||||
Other Investments | ( | ( | ( | |||||||
Total Assets – Asset Management and Strategic Holdings | $ | $ | $ | $( | $ | $( | $ | $ | $( | $ |
Insurance | ||||||||||
AFS Fixed Maturity Securities: | ||||||||||
Corporate Fixed Maturity Securities | $ | $ | $ | $ | $ | $( | $( | $ | $ | $( |
Structured Securities | ( | ( | ||||||||
Total AFS Fixed Maturity Securities | $ | $ | $ | $ | $ | $( | $( | $ | $ | $( |
Trading Fixed Maturity Securities | ( | |||||||||
Mortgage and Other Loan Receivables | ||||||||||
Real Assets | ( | ( | ||||||||
Other Investments | ( | ( | ||||||||
Funds Withheld Receivable at Interest | ( | |||||||||
Reinsurance Recoverable | ( | |||||||||
Total Assets – Insurance | $ | $ | $ | $ | $ | $( | $( | $ | $( | $( |
Total | $ | $ | $ | $( | $ | $( | $( | $ | $( | $( |
Three Months Ended March 31, 2025 | ||||||||||
Balance, Beg. of Period | Transfers In / (Out) – Changes in Consolidation | Transfers In | Transfers Out | Net Purchases/ Issuances/ Sales/ Settlements | Net Unrealized and Realized Gains (Losses) | Change in OCI | Balance, End of Period | Changes in Net Unrealized Gains (Losses) Included in Earnings related to Level III Assets and Liabilities still held as of the Reporting Date | Changes in Net Unrealized Gains (Losses) Included in OCI related to Level III Assets and Liabilities still held as of the Reporting Date | |
Assets | ||||||||||
Asset Management and Strategic Holdings | ||||||||||
Private Equity | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Credit | ( | ( | ||||||||
Real Assets | ( | |||||||||
Other Investments | ( | |||||||||
Total Assets – Asset Management and Strategic Holdings | $ | $ | $ | $( | $ | $ | $ | $ | $ | $ |
Insurance | ||||||||||
AFS Fixed Maturity Securities: | ||||||||||
Corporate Fixed Maturity Securities | $ | $ | $ | $( | $ | $ | $ | $ | $ | $ |
Structured Securities | ( | |||||||||
Total AFS Fixed Maturity Securities | $ | $ | $ | $( | $ | $ | $ | $ | $ | $ |
Trading Fixed Maturity Securities | ( | ( | ( | |||||||
Mortgage and Other Loan Receivables | ||||||||||
Real Assets | ||||||||||
Other Investments | ||||||||||
Funds Withheld Receivable at Interest | ( | |||||||||
Reinsurance Recoverable | ( | |||||||||
Total Assets – Insurance | $ | $ | $ | $( | $ | $ | $ | $ | $ | $ |
Total | $ | $ | $ | $( | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2026 | |||||
Purchases | Issuances | Sales | Settlements | Net Purchases/ Issuances/Sales/ Settlements | |
Assets | |||||
Asset Management and Strategic Holdings | |||||
Private Equity | $ | $ | $( | $ | $ |
Credit | ( | ||||
Real Assets | ( | ( | |||
Other Investments | ( | ( | ( | ||
Total Assets – Asset Management and Strategic Holdings | $ | $ | $( | $ | $ |
Insurance | |||||
AFS Fixed Maturity Securities: | |||||
Corporate Fixed Maturity Securities | $ | $ | $( | $( | $ |
Structured Securities | ( | ( | |||
Total AFS Fixed Maturity Securities | $ | $ | $( | $( | $ |
Trading Fixed Maturity Securities | ( | ( | |||
Mortgage and Other Loan Receivables | ( | ( | |||
Real Assets | ( | ( | |||
Other Investments | ( | ||||
Reinsurance Recoverable | ( | ( | |||
Total Assets – Insurance | $ | $ | $( | $( | $ |
Total | $ | $ | $( | $( | $ |
Three Months Ended March 31, 2025 | |||||
Purchases | Issuances | Sales | Settlements | Net Purchases/ Issuances/Sales/ Settlements | |
Assets | |||||
Asset Management and Strategic Holdings | |||||
Private Equity | $ | $ | $( | $ | $ |
Credit | ( | ( | ( | ||
Real Assets | ( | ( | |||
Other Investments | ( | ( | |||
Total Assets – Asset Management and Strategic Holdings | $ | $ | $( | $( | $ |
Insurance | |||||
AFS Fixed Maturity Securities: | |||||
Corporate Fixed Maturity Securities | $ | $ | $( | $( | $ |
Structured Securities | ( | ( | |||
Total AFS Fixed Maturity Securities | $ | $ | $( | $( | $ |
Trading Fixed Maturity Securities | ( | ( | |||
Mortgage and Other Loan Receivables | ( | ( | |||
Real Assets | ( | ||||
Other Investments | |||||
Reinsurance Recoverable | ( | ( | |||
Total Assets – Insurance | $ | $ | $( | $( | $ |
Total | $ | $ | $( | $( | $ |
Three Months Ended March 31, 2026 | |||||||||
Balance, Beg. of Period | Transfers In / (Out) - Changes in Consolidation | Transfers In | Transfers Out | Net Purchases/ Sales/ Settlements/ Issuances | Net Unrealized and Realized Gains (Losses) | Change in OCI | Balance, End of Period | Changes in Net Unrealized Gains (Losses) Included in Earnings related to Level III Assets and Liabilities still held as of the Reporting Date | |
Liabilities | |||||||||
Asset Management and Strategic Holdings | |||||||||
Unfunded Revolver Commitments | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Total Liabilities – Asset Management and Strategic Holdings | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Insurance | |||||||||
Policy Liabilities | $ | $ | $ | $ | $ | $ | $( | $ | $ |
Closed Block Policy Liabilities | ( | ( | |||||||
Funds Withheld Payable at Interest | ( | ( | ( | ||||||
Embedded Derivative – Interest- Sensitive Life Products | ( | ( | |||||||
Embedded Derivative – Annuity Products | ( | ||||||||
Total Liabilities – Insurance | $ | $ | $ | $ | $( | $( | $( | $ | $ |
Total | $ | $ | $ | $ | $( | $( | $( | $ | $ |
Three Months Ended March 31, 2025 | |||||||||
Balance, Beg. Of Period | Transfers In / (Out) - Changes In Consolidation | Transfers In | Transfers Out | Net Purchases/ sales/ settlements/ issuances | Net Unrealized And Realized Gains (Losses) | Change in OCI | Balance, End Of Period | Changes In Net Unrealized Gains (Losses) Included In Earnings Related To Level Iii Assets And Liabilities Still Held As Of The Reporting Date | |
Liabilities | |||||||||
Asset Management and Strategic Holdings | |||||||||
Unfunded Revolver Commitments | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Total Liabilities – Asset Management and Strategic Holdings | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Insurance | |||||||||
Policy Liabilities | $ | $ | $ | $ | $ | $ | $( | $ | $ |
Closed Block Policy Liabilities | ( | ||||||||
Funds Withheld Payable at Interest | ( | ( | |||||||
Embedded Derivative – Interest- Sensitive Life Products | ( | ( | |||||||
Embedded Derivative – Annuity Products | ( | ||||||||
Total Liabilities – Insurance | $ | $ | $ | $ | $ | $ | $( | $ | $ |
Total | $ | $ | $ | $ | $ | $ | $( | $ | $ |
Three Months Ended March 31, 2026 | |||
Issuances | Settlements | Net Issuances/Settlements | |
Liabilities | |||
Asset Management and Strategic Holdings | |||
Unfunded Revolver Commitments | $ | $ | $ |
Total Liabilities – Asset Management and Strategic Holdings | $ | $ | $ |
Insurance | |||
Policy Liabilities | $ | $( | $ |
Closed Block Policy Liabilities | ( | ( | |
Embedded Derivative – Interest-Sensitive Life Products | ( | ( | |
Embedded Derivative – Annuity Products | ( | ||
Total Liabilities – Insurance | $ | $( | $( |
Total | $ | $( | $( |
Three Months Ended March 31, 2025 | |||
Issuances | Settlements | Net Issuances/Settlements | |
Liabilities | |||
Asset Management and Strategic Holdings | |||
Unfunded Revolver Commitments | $ | $ | $ |
Total Liabilities – Asset Management and Strategic Holdings | $ | $ | $ |
Insurance | |||
Policy Liabilities | $ | $( | $ |
Closed Block Policy Liabilities | ( | ( | |
Embedded Derivative – Interest-Sensitive Life Products | ( | ( | |
Embedded Derivative – Annuity Products | ( | ||
Total Liabilities – Insurance | $ | $( | $ |
Total | $ | $( | $ |
Level III Assets | Fair Value March 31, 2026 | Valuation Methodologies & Inputs | Unobservable Input(s) (1) | Weighted Average (2) | Range | Impact To Valuation From An Increase In Input (3) | ||||||
ASSET MANAGEMENT AND STRATEGIC HOLDINGS | ||||||||||||
Private Equity | $ | Inputs to market comparables, discounted cash flow and transaction price | Weight Ascribed to Market Comparables | (4) | ||||||||
Weight Ascribed to Discounted Cash Flow | (5) | |||||||||||
Weight Ascribed to Transaction Price/Other | (6) | |||||||||||
Market comparables | Enterprise Value/LTM EBITDA Multiple | Increase | ||||||||||
Enterprise Value/Forward EBITDA Multiple | Increase | |||||||||||
Discounted cash flow | Discount Rate | Decrease | ||||||||||
Enterprise Value/EBITDA Exit Multiple | Increase | |||||||||||
Credit | $ | Yield Analysis | Yield | Decrease | ||||||||
Net Leverage | Decrease | |||||||||||
EBITDA Multiple | Increase | |||||||||||
Real Assets | $ | |||||||||||
Inputs to market comparables, discounted cash flow, direct income capitalization and transaction price | Weight Ascribed to Direct Income Capitalization | (7) | ||||||||||
Weight Ascribed to Discounted Cash Flow | (5) | |||||||||||
Weight Ascribed to Market Comparables/ Other | (4) (6) | |||||||||||
Market comparables | Enterprise Value/LTM EBITDA Multiple | Increase | ||||||||||
Enterprise Value/Forward EBITDA Multiple | Increase | |||||||||||
Direct income capitalization | Current Capitalization Rate | Decrease | ||||||||||
Discounted cash flow | Exit Capitalization Rate | Decrease | ||||||||||
Unlevered Discount Rate | Decrease | |||||||||||
Discount rate | Decrease | |||||||||||
Enterprise Value/EBITDA Exit Multiple | Increase | |||||||||||
Other Investments | $ | (8) | Inputs to market comparables, discounted cash flow and transaction price | Weight Ascribed to Market Comparables | (4) | |||||||
Weight Ascribed to Discounted Cash Flow | (5) | |||||||||||
Weight Ascribed to Transaction Price | (6) | |||||||||||
Market comparables | Enterprise Value/LTM EBITDA Multiple | Increase | ||||||||||
Enterprise Value/Forward EBITDA Multiple | Increase | |||||||||||
Discounted cash flow | Discount Rate | Decrease | ||||||||||
Enterprise Value/EBITDA Exit Multiple | Increase | |||||||||||
INSURANCE(9) | ||||||||||||
Corporate Fixed Maturity Securities | $ | Discounted cash flow | Discount Spread | Decrease | ||||||||
Structured Securities | $ | Discounted cash flow | Discount Spread | Decrease | ||||||||
Mortgage and Other Loan Receivables | $ | Discounted cash flow | Discount Spread | Decrease | ||||||||
Real Assets | $ | Discounted cash flow | Discount Rate | Decrease | ||||||||
Terminal Capitalization Rate | Decrease | |||||||||||
Reinsurance Recoverable | $ | Present value of expenses paid from the open block plus the cost of capital held in support of the liabilities. | Expense Assumption | $ | The average expense assumption is between $ $ increased by inflation. The annual inflation rate was increased by | Increase | ||||||
Unobservable inputs are a market participant’s view of the expenses, a risk margin on the uncertainty of the level of expenses and a cost of capital on the capital held in support of the liabilities. | Expense Risk Margin | Decrease | ||||||||||
Cost of Capital | Increase | |||||||||||
Discounted cash flow | Mortality Rate | Increase | ||||||||||
Surrender Rate | Increase |
Level III Liabilities | Fair Value March 31, 2026 | Valuation Methodologies | Unobservable Input(s) (1) | Weighted Average (2) | Range | Impact To Valuation From An Increase In Input (3) | ||||||
ASSET MANAGEMENT AND STRATEGIC HOLDINGS | ||||||||||||
Unfunded Revolver Commitments | $ | Yield Analysis | Discount Rate | Decrease | ||||||||
INSURANCE(4) | ||||||||||||
Policy Liabilities | $ | Policy liabilities under fair value option: | ||||||||||
Present value of best estimate liability cash flows. Unobservable inputs include a market participant view of the risk margin included in the discount rate which reflects the variability of the cash flows. | Risk Margin Rate | Decrease | ||||||||||
Policyholder behavior is also a significant unobservable input, including lapse, surrender and mortality. | Surrender Rate | Decrease | ||||||||||
Mortality Rate | Increase | |||||||||||
Market risk benefit: | ||||||||||||
Fair value using a non-option and option valuation approach | Instrument-specific Credit Risk (10 and 30 Year) | Decrease | ||||||||||
Policyholder behavior is also a significant unobservable input, including lapse, surrender, and mortality. | Mortality Rate | Decrease | ||||||||||
Surrender Rate | Decrease | |||||||||||
Closed Block Policy Liabilities | $ | Present value of expenses paid from the open block plus the cost of capital held in support of the liabilities. | Expense Assumption | $ | The average expense assumption is between $ $ increased by inflation. The annual inflation rate was increased by | Increase | ||||||
Instrument-Specific Credit Risk | Decrease | |||||||||||
Unobservable inputs are a market participant’s view of the expenses, a risk margin on the uncertainty of the level of expenses and a cost of capital on the capital held in support of the liabilities. | Expense Risk Margin | Decrease | ||||||||||
Cost of Capital | Increase | |||||||||||
Discounted cash flow | Mortality Rate | Increase | ||||||||||
Surrender Rate | Increase | |||||||||||
Level III Liabilities | Fair Value March 31, 2026 | Valuation Methodologies | Unobservable Input(s) (1) | Weighted Average (2) | Range | Impact To Valuation From An Increase In Input (3) | ||||||
Embedded Derivative – Interest-Sensitive Life Products | $ | Policy persistency is a significant unobservable input. | Lapse Rate | Decrease | ||||||||
Mortality Rate | Decrease | |||||||||||
Future costs for options used to hedge the contract obligations | Option Budget Assumption | Increase | ||||||||||
Instrument-Specific Credit Risk | Decrease | |||||||||||
Embedded Derivative – Annuity Products | $ | Policyholder behavior is a significant unobservable input, including utilization and lapse. | Utilization: | |||||||||
Fixed-Indexed Annuity | Increase | |||||||||||
Surrender Rate: | ||||||||||||
Retail FIA | Increase | |||||||||||
Institutional FIA | Decrease | |||||||||||
Mortality Rate: | ||||||||||||
Retail FIA | Decrease | |||||||||||
Institutional FIA | Decrease | |||||||||||
Future costs for options used to hedge the contract obligations | Option Budget Assumption: | |||||||||||
Retail FIA | Increase | |||||||||||
Institutional FIA | Increase | |||||||||||
Instrument-Specific Credit Risk | Decrease |
Fair Value Hierarchy | |||||||||
As of March 31, 2026 | Carrying Value | Level I | Level II | Level III | Fair Value | ||||
($ in thousands) | |||||||||
Financial Assets: | |||||||||
Insurance | |||||||||
Mortgage and Other Loan Receivables | $ | $— | $ | $— | $ | $— | $ | $— | $ |
Policy Loans | — | — | — | — | |||||
FHLB Common Stock and Other Investments | — | — | — | — | |||||
Funds Withheld Receivables at Interest | 0 | 0 | 0 | — | |||||
Cash and Cash Equivalents | — | — | — | — | |||||
Restricted Cash and Cash Equivalents | — | — | — | — | |||||
Total Financial Assets | $ | $— | $ | $— | $ | $— | $ | $— | $ |
Financial Liabilities: | |||||||||
Insurance | |||||||||
Policy Liabilities – Policyholder Account Balances | $ | $— | $ | $— | $ | $— | $ | $— | $ |
Funds Withheld Payables at Interest | — | — | — | — | |||||
Debt Obligations | — | — | — | — | |||||
Securities Sold Under Agreements to Repurchase | — | — | — | — | |||||
Total Financial Liabilities | $ | $— | $ | $— | $ | $— | $ | $— | $ |
Fair Value Hierarchy | |||||||||
As of December 31, 2025 | Carrying Value | Level I | Level II | Level III | Fair Value | ||||
($ in thousands) | |||||||||
Financial Assets: | |||||||||
Insurance | |||||||||
Mortgage and Other Loan Receivables | $ | $ | $ | $ | $ | ||||
Policy Loans | |||||||||
FHLB Common Stock and Other Investments | |||||||||
Funds Withheld Receivables at Interest | |||||||||
Cash and Cash Equivalents | |||||||||
Restricted Cash and Cash Equivalents | |||||||||
Total Financial Assets | $ | $ | $ | $ | $ | ||||
Financial Liabilities: | |||||||||
Insurance | |||||||||
Policy Liabilities – Policyholder Account Balances | $ | $ | $ | $ | $ | ||||
Funds Withheld Payables at Interest | |||||||||
Debt Obligations | |||||||||
Securities Sold Under Agreements to Repurchase | |||||||||
Total Financial Liabilities | $ | $ | $ | $ | $ | ||||
March 31, 2026 | December 31, 2025 | ||
Assets | |||
Asset Management and Strategic Holdings | |||
Credit | $ | $ | |
Investments of Consolidated CFEs | |||
Real Assets | |||
Private Equity | |||
Other Investments | |||
Total Asset Management and Strategic Holdings (1) | $ | $ | |
Insurance | |||
Fixed Maturity Securities | $ | $ | |
Mortgage and Other Loan Receivables | |||
Real Assets | |||
Other Investments | |||
Reinsurance Recoverable | |||
Total Insurance | $ | $ | |
Total Assets | $ | $ | |
Liabilities | |||
Asset Management and Strategic Holdings | |||
Debt Obligations of Consolidated CFEs | $ | $ | |
Total Asset Management and Strategic Holdings | $ | $ | |
Insurance | |||
Policy Liabilities | $ | $ | |
Total Insurance | $ | $ | |
Total Liabilities | $ | $ |
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | |||||||||||
Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Total | Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Total | |||||||
Assets (1) | ||||||||||||
Asset Management and Strategic Holdings | ||||||||||||
Credit | $( | 0 | $ | $ | $ | $( | $( | |||||
Investments of Consolidated CFEs | ( | ( | ( | ( | ( | ( | ||||||
Real Assets | ( | ( | ( | |||||||||
Private Equity | ( | ( | ( | ( | ||||||||
Other Investments | ( | ( | ||||||||||
Total Asset Management and Strategic Holdings | $( | $( | $( | $( | $( | $( | ||||||
Insurance | ||||||||||||
Fixed Maturity Securities | $( | $ | $( | $ | $( | $( | ||||||
Mortgage and Other Loan Receivables | ||||||||||||
Real Assets | ||||||||||||
Other Investments | ( | ( | ( | ( | ||||||||
Total Insurance | $( | $ | $( | $ | $ | $ | ||||||
Total Assets | $( | $( | $( | $( | $( | $( | ||||||
Liabilities | ||||||||||||
Asset Management and Strategic Holdings | ||||||||||||
Debt Obligations of Consolidated CFEs | $( | $ | $ | $( | $ | $ | ||||||
Total Asset Management and Strategic Holdings | $( | $ | $ | $( | $ | $ | ||||||
Insurance | ||||||||||||
Policy Liabilities | $ | $ | $ | $ | $( | $( | ||||||
Total Insurance | $ | $ | $ | $ | $( | $( | ||||||
Total Liabilities | $( | $ | $ | $( | $ | $ | ||||||
March 31, | December 31, | ||
2026 | 2025 | ||
Deferred Acquisition Costs, or "DAC" | $ | $ | |
Value of Business Acquired | |||
Cost-of-Reinsurance Intangibles | |||
Deferred Sales Inducements | |||
Total Insurance Intangible Assets | $ | $ |
Three Months Ended March 31, 2026 | |||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Other | Total | |||||
Balance, as of the Beginning of the Period | $ | $ | $ | $ | $ | ||||
Capitalizations | |||||||||
Amortization Expense | ( | ( | ( | ( | ( | ||||
Balance, as of the End of the Period | $ | $ | $ | $ | $ | ||||
Three Months Ended March 31, 2025 | |||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Other | Total | |||||
Balance, as of the Beginning of the Period | $ | $ | $ | $ | $ | ||||
Capitalizations | |||||||||
Amortization Expense | ( | ( | ( | ( | ( | ||||
Balance, as of the End of the Period | $ | $ | $ | $ | $ | ||||
Three Months Ended March 31, 2026 | |||||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Variable Annuities | Other | Total | ||||||
Balance, as of the Beginning of the Period | $ | $ | $ | $ | $ | $ | |||||
Amortization Expense | ( | ( | ( | ( | ( | ( | |||||
Balance, as of the End of the Period | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, 2025 | |||||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Variable Annuities | Other | Total | ||||||
Balance, as of the Beginning of the Period | $ | $ | $ | $ | $ | $ | |||||
Amortization Expense | ( | ( | ( | ( | ( | ( | |||||
Balance, as of the End of the Period | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, 2026 | |||||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Variable Annuities | Other | Total | ||||||
Balance, as of the Beginning of the Period | $ | $ | $ | $ | $ | $ | |||||
Amortization Expense | ( | ( | ( | ( | ( | ( | |||||
Balance, as of the End of the Period | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, 2025 | |||||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Variable Annuities | Other | Total | ||||||
Balance, as of the Beginning of the Period | $ | $ | $ | $ | $ | $ | |||||
Amortization Expense | ( | ( | ( | ( | ( | ( | |||||
Balance, as of the End of the Period | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, 2026 | |
Fixed Indexed Annuities | |
Balance, as of the Beginning of the Period | $ |
Capitalizations | |
Amortization Expense | ( |
Balance, as of the End of the Period | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Preneed | ||||
Balance, as of the Beginning of the Period | $ | $ | ||
Deferral | ||||
Amortized to Income during the Period | ( | ( | ||
Balance, as of the End of the Period | $ | $ | ||
March 31, 2026 | December 31, 2025 | ||
Policy Liabilities: | |||
Direct | $ | $ | |
Assumed | |||
Total Policy Liabilities | |||
Ceded(1) | ( | ( | |
Net Policy Liabilities | $ | $ |
As of March 31, 2026 | As of December 31, 2025 | ||||||||||
A.M. Best Rating(1) | Reinsurance Recoverable and Funds Withheld Receivable at Interest | Credit Enhancements(2) | Net Reinsurance Credit Exposure(3) | Reinsurance Recoverable and Funds Withheld Receivable at Interest | Credit Enhancements(2) | Net Reinsurance Credit Exposure(3) | |||||
A++ | $ | $ | $ | $ | $ | $ | |||||
A+ | |||||||||||
A | |||||||||||
A- | |||||||||||
B++ | |||||||||||
B+ | |||||||||||
B | |||||||||||
B- | |||||||||||
C++/C+ | |||||||||||
Not Rated or Private Rating(4) | |||||||||||
Total | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net Premiums: | |||
Direct | $ | $ | |
Assumed | |||
Ceded | ( | ( | |
Net Premiums | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Policy Fees: | |||
Direct | $ | $ | |
Assumed | |||
Ceded | ( | ( | |
Net Policy Fees | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net Policy Benefits and Claims: | |||
Direct | $ | $ | |
Assumed | |||
Ceded | ( | ( | |
Net Policy Benefits and Claims | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net Income (Loss) Attributable to KKR & Co. Inc. Common Stockholders | $ | $( | |
(-) Accumulated Series D Mandatory Convertible Preferred Dividend (1) | |||
Net Income (Loss) Available to KKR & Co. Inc. Common Stockholders - Basic | $ | $( | |
(+) Series D Mandatory Convertible Preferred Dividend (if dilutive) (2) | |||
Net Income (Loss) Available to KKR & Co. Inc. Common Stockholders - Diluted | $ | $( | |
Basic Net Income (Loss) Per Share of Common Stock | |||
Weighted Average Shares of Common Stock Outstanding - Basic | |||
Net Income (Loss) Attributable to KKR & Co. Inc. Per Share of Common Stock - Basic | $ | $( | |
Diluted Net Income (Loss) Per Share of Common Stock | |||
Weighted Average Shares of Common Stock Outstanding - Basic | |||
Incremental Common Shares: | |||
Assumed vesting of dilutive equity awards (3) | |||
Assumed conversion of Series D Mandatory Convertible Preferred Stock (2) | |||
Weighted Average Shares of Common Stock Outstanding - Diluted | |||
Net Income (Loss) Attributable to KKR & Co. Inc. Per Share of Common Stock - Diluted | $ | $( | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Weighted Average Vested Restricted Holdings Units | |||
March 31, 2026 | December 31, 2025 | ||
Asset Management and Strategic Holdings | |||
Unsettled Investment Sales (1) | $ | $ | |
Receivables | |||
Due from Broker (2) | |||
Deferred Tax Assets, net | |||
Interest Receivable | |||
Fixed Assets, net (3) | |||
Foreign Exchange Contracts and Options (4) | |||
Goodwill (5)(6) | |||
Intangible Assets (6)(7) | |||
Derivative Assets | |||
Prepaid Taxes | |||
Prepaid Expenses | |||
Operating Lease Right of Use Assets (8) | |||
Deferred Financing Costs | |||
Other | |||
Total Asset Management and Strategic Holdings | $ | $ | |
Insurance | |||
Deferred Tax Assets, net | $ | $ | |
Accrued Investment Income | |||
Goodwill | |||
Intangible Assets(9) | |||
Premiums and Other Account Receivables | |||
Other | |||
Derivative Assets | |||
Operating Lease Right of Use Assets(8) | |||
Market Risk Benefit Assets | |||
Unsettled Investment Sales(1) and Derivative Collateral Receivables | |||
Total Insurance | $ | $ | |
Total Other Assets | $ | $ |
March 31, 2026 | December 31, 2025 | ||
Asset Management and Strategic Holdings | |||
Amounts Payable to Carry Pool (1) | $ | $ | |
Unsettled Investment Purchases (2) | |||
Securities Sold Short (3) | |||
Derivative Liabilities | |||
Accrued Compensation and Benefits | |||
Interest Payable | |||
Foreign Exchange Contracts and Options (4) | |||
Accounts Payable and Accrued Expenses | |||
Taxes Payable | |||
Uncertain Tax Positions | |||
Unfunded Revolver Commitments | |||
Operating Lease Liabilities (5) | |||
Deferred Tax Liabilities, net | |||
Other Liabilities | |||
Total Asset Management and Strategic Holdings | $ | $ | |
Insurance | |||
Unsettled Investment Purchases(2) and Derivative Collateral Liabilities | $ | $ | |
Accrued Expenses | |||
Derivative Liabilities | |||
Securities Sold Under Agreements to Repurchase | |||
Insurance Operations Balances in Course of Settlement | |||
Operating Lease Liabilities(5) | |||
Accrued Employee Related Expenses | |||
Interest Payable | |||
Tax Payable to Former Parent Company | |||
Other Tax Related Liabilities | |||
Accounts and Commissions Payable | |||
Current Income Tax Payable | |||
Total Insurance | $ | $ | |
Total Accrued Expenses and Other Liabilities | $ | $ |
March 31, 2026 | December 31, 2025 | ||
Investments | $ | $ | |
Due from (to) Affiliates, net | |||
Maximum Exposure to Loss | $ | $ | |
Insurance | |||
Real Assets | $ | $ | |
Other Investments | |||
Maximum Exposure to Loss | $ | $ | |
Total Maximum Exposure to Loss | $ | $ |
March 31, 2026 | December 31, 2025 | |||||||||
By remaining maturity at period end date | Financing Available | Principal | Carrying Value | Fair Value | Financing Available | Principal | Carrying Value | Fair Value | ||
Revolving Credit Facilities: (1) | ||||||||||
Under 1 Year | $ | $— | $— | $— | $ | $— | $— | $— | ||
1-5 Years | — | — | — | — | — | — | ||||
After 5 Years | — | — | — | — | — | — | ||||
Subtotal | — | — | — | — | — | — | ||||
KKR USD Senior Notes: (2)(3)(5)(7) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
KKR Yen Senior Notes: (2)(3)(5) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
KKR Euro Senior Notes: (2)(3)(5) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
KKR Subordinated Notes: (2)(3)(6) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
KFN USD Senior Notes: (2)(3)(4) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
Total KKR & KFN Notes | ||||||||||
Other Debt Obligations: (1)(2)(7) | ||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | ||
March 31, 2026 | December 31, 2025 | |
KKR USD Senior Notes | ||
KKR Yen Senior Notes | ||
KKR Euro Senior Notes | ||
KKR Subordinated Notes | ||
KFN USD Senior Notes |
Financing Available | Principal | Carrying Value(1) | Fair Value | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | ||||||
Financing Facilities of Consolidated Funds and Other | $ | $ | $ | $ | |||||||
Debt Obligations of Consolidated CFEs | (2) | ||||||||||
$ | $ | $ | $ |
March 31, 2026 | December 31, 2025 | |||||||||
By remaining maturity at period end date | Financing Available | Principal | Carrying Value(1) | Fair Value(2) | Financing Available | Principal | Carrying Value(1) | Fair Value(2) | ||
Revolving Credit Facilities: | ||||||||||
Under 1 Year | $ | $ | $ | $ | $ | $ | $ | $ | ||
1-5 Years | ||||||||||
After 5 Years | ||||||||||
Subtotal | ||||||||||
Senior Notes: (4) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
Subordinated Notes: (4) | ||||||||||
Under 1 Year | — | — | ||||||||
1-5 Years | — | — | ||||||||
After 5 Years | — | — | ||||||||
Subtotal | — | — | ||||||||
Debt Obligations of Consolidated Special Purpose Vehicles(3) | ||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | ||
March 31, 2026 | December 31, 2025 | |
Senior Notes | ||
Subordinated Notes |
March 31, 2026 | December 31, 2025 | ||
Policyholders’ Account Balances | $ | $ | |
Liability for Future Policy Benefits | |||
Additional Liability for Annuitization, Death, or Other Insurance Benefits | |||
Market Risk Benefit Liability | |||
Other Policy-Related Liabilities(1) | |||
Total Policy Liabilities | $ | $ |
Three Months Ended March 31, 2026 | |||||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Funding Agreements | Other(1) | Total | ||||||
Balance as of Beginning of Period | $ | $ | $ | $ | $ | $ | |||||
Issuances and Premiums Received | |||||||||||
Benefit Payments, Surrenders, and Withdrawals | ( | ( | ( | ( | ( | ( | |||||
Interest(2) | |||||||||||
Other Activity(3) | ( | ( | ( | ( | |||||||
Balance as of End of Period | $ | $ | $ | $ | $ | $ | |||||
Less: Reinsurance Recoverable | ( | ( | ( | ( | ( | ( | |||||
Balance as of End of Period, Net of Reinsurance Recoverable | $ | $ | $ | $ | $ | $ | |||||
Average Interest Rate | |||||||||||
Net Amount at Risk, Gross of Reinsurance(4) | $ | $ | $ | $ | $ | $ | |||||
Cash Surrender Value(5) | $ | $ | $ | $ | $ | $ | |||||
Three Months Ended March 31, 2025 | |||||||||||
Fixed Rate Annuities | Fixed Indexed Annuities | Interest Sensitive Life | Funding Agreements | Other(1) | Total | ||||||
Balance as of Beginning of Period | $ | $ | $ | $ | $ | $ | |||||
Issuances and Premiums Received | |||||||||||
Benefit Payments, Surrenders, and Withdrawals | ( | ( | ( | ( | ( | ( | |||||
Interest(2) | |||||||||||
Other Activity(3) | ( | ( | ( | ||||||||
Balance as of End of Period | $ | $ | $ | $ | $ | $ | |||||
Less: Reinsurance Recoverable | ( | ( | ( | ( | ( | ||||||
Balance as of End of Period, Net of Reinsurance Recoverable | $ | $ | $ | $ | $ | $ | |||||
Average Interest Rate | |||||||||||
Net Amount at Risk, Gross of Reinsurance(4) | $ | $ | $ | $ | $ | $ | |||||
Cash Surrender Value(5) | $ | $ | $ | $ | $ | $ | |||||
As of March 31, 2026 | |||||||||||
Account Values with Adjustable Crediting Rates Subject to Guaranteed Minimums: | |||||||||||
Range of Guaranteed Minimum Crediting Rates: | At Guaranteed Minimum | 1 - 49 Above Guaranteed Minimum | 50 - 99 Above Guaranteed Minimum | 100 - 150 Above Guaranteed Minimum | Greater Than 150 bps Above Guaranteed Minimum | Total | |||||
Less Than | $ | $ | $ | $ | $ | $ | |||||
Greater Than | |||||||||||
Total | $ | $ | $ | $ | $ | $ | |||||
Percentage of Total | |||||||||||
As of December 31, 2025 | |||||||||||
Account Values with Adjustable Crediting Rates Subject to Guaranteed Minimums: | |||||||||||
Range of Guaranteed Minimum Crediting Rates: | At Guaranteed Minimum | 1 - 49 Above Guaranteed Minimum | 50 - 99 Above Guaranteed Minimum | 100 - 150 Above Guaranteed Minimum | Greater Than 150 bps Above Guaranteed Minimum | Total | |||||
Less Than | $ | $ | $ | $ | $ | $ | |||||
Greater Than | |||||||||||
Total | $ | $ | $ | $ | $ | $ | |||||
Percentage of Total | |||||||||||
Three Months Ended | ||||||||||||
March 31, 2026 | March 31, 2025 | |||||||||||
Payout Annuities(1) | Other(2) | Total | Payout Annuities(1) | Other(2) | Total | |||||||
Present Value of Expected Net Premiums | ||||||||||||
Balance as of Beginning of Period | $ | $( | $( | $ | $( | $( | ||||||
— | — | — | — | — | — | |||||||
Balance at Original Discount Rate | $ | $( | $( | $ | $( | $( | ||||||
Effect of Actual Variances from Expected Experience | ( | ( | ||||||||||
Adjusted Beginning of Period Balance | ( | ( | ( | ( | ||||||||
Issuances | ( | ( | ( | ( | ||||||||
Interest | ( | ( | ( | ( | ||||||||
Net Premiums Collected | ||||||||||||
Ending Balance at Original Discount Rate | ( | ( | ( | ( | ||||||||
Effect of Changes in Discount Rate Assumptions | ||||||||||||
Balance as of End of Period | $ | $( | $( | $ | $( | $( | ||||||
Present Value of Expected Future Policy Benefits | ||||||||||||
Balance as of Beginning of Period | $ | $ | $ | $ | $ | $ | ||||||
Balance at Original Discount Rate | $ | $ | $ | $ | $ | $ | ||||||
Effect of Actual Variances from Expected Experience | ( | ( | ( | ( | ( | ( | ||||||
Adjusted Beginning of Period Balance | ||||||||||||
Issuances | ||||||||||||
Interest | ||||||||||||
Benefit Payments | ( | ( | ( | ( | ( | ( | ||||||
Ending Balance at Original Discount Rate | ||||||||||||
Effect of Changes in Discount Rate Assumptions | ( | ( | ( | ( | ( | ( | ||||||
Balance as of End of Period | ||||||||||||
Net Liability for Future Policy Benefits | ||||||||||||
Less: Reinsurance Recoverable(3) | ( | ( | ( | ( | ( | ( | ||||||
Net Liability for Future Policy Benefits, Net of Reinsurance Recoverables | $ | $ | $ | $ | $ | $ | ||||||
Gross Premiums | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Payout Annuities | $ | $ | |
Other | |||
Total Products | $ | $ | |
As of March 31, 2026 | |||
Payout Annuities | Other | ||
Weighted-Average Interest Rates, Original Discount Rate | |||
Weighted-Average Interest Rates, Current Discount Rate | |||
Weighted-Average Liability Duration (Years, Current Rates) | |||
As of December 31, 2025 | |||
Payout Annuities | Other | ||
Weighted-Average Interest Rates, Original Discount Rate | |||
Weighted-Average Interest Rates, Current Discount Rate | |||
Weighted-Average Liability Duration (Years, Current Rates) | |||
As of March 31, 2026 | ||||
Payout Annuities | Other | |||
Expected Future Benefit Payments, Undiscounted | $ | $ | ||
Expected Future Benefit Payments, Discounted (Original Discount Rate) | ||||
Expected Future Benefit Payments, Discounted (Current Discount Rate) | ||||
Expected Future Gross Premiums, Undiscounted | ||||
Expected Future Gross Premiums, Discounted (Original Discount Rate) | ||||
Expected Future Gross Premiums, Discounted (Current Discount Rate) | ||||
As of December 31, 2025 | ||||
Payout Annuities | Other | |||
Expected Future Benefit Payments, Undiscounted | $ | $ | ||
Expected Future Benefit Payments, Discounted (Original Discount Rate) | ||||
Expected Future Benefit Payments, Discounted (Current Discount Rate) | ||||
Expected Future Gross Premiums, Undiscounted | ||||
Expected Future Gross Premiums, Discounted (Original Discount Rate) | ||||
Expected Future Gross Premiums, Discounted (Current Discount Rate) | ||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Balance as of Beginning of Period | $ | $ | |
Effect of Changes in Experience | ( | ( | |
Adjusted Balance as of Beginning of Period | |||
Issuances | |||
Assessments | |||
Benefits Paid | ( | ( | |
Interest | |||
Balance as of End of Period | |||
Less: Impact of Unrealized Investment Gains and Losses | |||
Less: Reinsurance Recoverable, End of Period | |||
Balance, End of Period, Net of Reinsurance Recoverable and Impact of Unrealized Investment Gains and Losses | $ | $ | |
Gross Assessments | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Total Amount Recognized Within Revenue in the Consolidated Statements of Operations | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
Weighted-Average Interest, Current Discount Rate | |||
Weighted-Average Liability Duration (Years) | |||
Three Months Ended | ||||||||||||
March 31, 2026 | March 31, 2025 | |||||||||||
Fixed- Indexed Annuity | Variable- and Other Annuities | Total | Fixed- Indexed Annuity | Variable- and Other Annuities | Total | |||||||
Balance as of Beginning of Period | $ | $ | $ | $ | $ | $ | ||||||
Balance as of Beginning of Period, Before Impact of Changes in Instrument-Specific Credit Risk | $ | $ | $ | $ | $ | $ | ||||||
Issuances | ||||||||||||
Interest | ||||||||||||
Attributed Fees Collected | ||||||||||||
Benefit Payments | ( | ( | ( | ( | ( | ( | ||||||
Effect of Changes in Interest Rates | ( | ( | ( | |||||||||
Effect of Changes in Equity Markets | ||||||||||||
Effect of Actual Experience Different from Assumptions | ( | ( | ||||||||||
Effect of Changes in Other Future Expected Assumptions | ||||||||||||
Balance as of End of Period Before Impact of Changes in Instrument-Specific Credit Risk | ||||||||||||
Effect of Changes in Instrument-Specific Credit Risk | ||||||||||||
Balance as of End of Period | ||||||||||||
Less: Reinsurance Recoverable as of the End of the Period | ( | ( | ( | ( | ( | |||||||
Balance as of End of Period, Net of Reinsurance Recoverable | $ | $ | $ | $ | $ | $ | ||||||
Net Amount at Risk | $ | $ | $ | $ | $ | $ | ||||||
Weighted-average Attained Age of Contract holders (Years) | ||||||||||||
As of March 31, 2026 | As of December 31, 2025 | |||||||||||
Asset | Liability | Net | Asset | Liability | Net | |||||||
Fixed-Indexed Annuities | $ | $ | $( | $ | $ | $( | ||||||
Variable- and Other Annuities | ( | ( | ||||||||||
Total | $ | $ | $( | $ | $ | $( | ||||||
Three Months Ended | ||||||||||||
March 31, 2026 | March 31, 2025 | |||||||||||
Variable Annuities | Interest- Sensitive Life | Total | Variable Annuities | Interest- Sensitive Life | Total | |||||||
Balance as of Beginning of Period | $ | $ | $ | $ | $ | $ | ||||||
Premiums and Deposits | ||||||||||||
Surrenders, Withdrawals and Benefit Payments | ( | ( | ( | ( | ( | ( | ||||||
Investment Performance | ( | ( | ( | ( | ( | ( | ||||||
Other | ( | ( | ( | ( | ( | ( | ||||||
Balance as of End of Period | $ | $ | $ | $ | $ | $ | ||||||
Cash Surrender Value as of End of Period(1) | $ | $ | $ | $ | $ | $ | ||||||
March 31, 2026 | December 31, 2025 | ||
Asset Type: | |||
Managed Volatility Equity/Fixed Income Blended Fund | $ | $ | |
Equity | |||
Fixed Income | |||
Money Market | |||
Alternative | |||
Total Assets Supporting Separate Account Liabilities | $ | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Asset Management(1) | $ | $ | |
Insurance | |||
Total | $ | $ | |
Shares | Weighted Average Grant Date Fair Value | ||
Balance, January 1, 2026 | $ | ||
Granted | |||
Vested | ( | ||
Forfeitures | ( | ||
Balance, March 31, 2026 | $ |
Weighted Average | Range | ||
Grant Date Fair Value | $ | $ | |
Closing KKR share price as of valuation date | $ | $ | |
Risk Free Rate | |||
Volatility | |||
Dividend Yield | |||
Expected Cost of Equity |
Shares | Weighted Average Grant Date Fair Value | ||
Balance, January 1, 2026 | $ | ||
Granted | |||
Vested | ( | ||
Forfeitures | ( | ||
Balance, March 31, 2026 | $ |
Grant Date Fair Value | $ |
Closing KKR share price as of valuation date | $ |
Risk Free Rate | |
Volatility | |
Dividend Yield | |
Expected Cost of Equity |
March 31, 2026 | December 31, 2025 | ||
Amounts Due From Unconsolidated Investment Funds | $ | $ | |
Amounts Due From Portfolio Companies | |||
Due From Affiliates | $ | $ |
March 31, 2026 | December 31, 2025 | ||
Amounts Due to Current and Former Employees Under the Tax Receivable Agreement | $ | $ | |
Amounts Due to Unconsolidated Investment Funds | |||
Due to Affiliates | $ | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Asset Management | ||||
Management Fees (1)(2) | $ | $ | ||
Transaction and Monitoring Fees, Net | ||||
Fee Related Performance Revenues | ||||
Fee Related Compensation | ( | ( | ||
Other Operating Expenses | ( | ( | ||
Fee Related Earnings | ||||
Realized Performance Income | ||||
Realized Performance Income Compensation | ( | ( | ||
Realized Investment Income (3) | ||||
Realized Investment Income Compensation | ( | ( | ||
Asset Management Segment Earnings | $ | $ | ||
Insurance | ||||
Net Investment Income (1) (4) | $ | $ | ||
Net Cost of Insurance | ( | ( | ||
General, Administrative and Other | ( | ( | ||
Insurance Operating Earnings | $ | $ | ||
Strategic Holdings | ||||
Dividends, Net (2) | $ | $ | ||
Strategic Holdings Operating Earnings | ||||
Net Realized Investment Income(3) | ||||
Strategic Holdings Segment Earnings | $ | $ | ||
Total Segment Earnings | $ | $ | ||
As of March 31, | ||||
2026 | 2025 | |||
Segment Assets: | ||||
Asset Management | $ | $ | ||
Insurance | ||||
Strategic Holdings | ||||
Total Segment Assets | $ | $ | ||
Three Months Ended March 31, | ||||
Non-Cash Expenses Excluded from Segment Earnings | 2026 | 2025 | ||
Equity Based Compensation | ||||
Asset Management | $ | $ | ||
Insurance | ||||
Total Non-Cash Expenses | $ | $ | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Total GAAP Revenues | $ | $ | ||
Impact of Consolidation and Other | ||||
Asset Management Adjustments: | ||||
Capital Allocation-Based Income (Loss) (GAAP) | ( | ( | ||
Realized Carried Interest | ||||
Realized Investment Income | ||||
Capstone Fees | ( | ( | ||
Expense Reimbursements | ( | ( | ||
Strategic Holdings Adjustments: | ||||
Realized Investment Income and Dividends | ||||
Insurance Adjustments: | ||||
Net Premiums | ( | ( | ||
Policy Fees | ( | ( | ||
Other Income | ( | ( | ||
(Gains) Losses from Investments(1) | ||||
Non-Operating Changes in Policy Liabilities and Derivatives | ||||
Total Segment Revenues (2) | $ | $ | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Total GAAP Expenses | $ | $ | |
Impact of Consolidation and Other | ( | ( | |
Asset Management Adjustments: | |||
Equity-based Compensation | ( | ( | |
Unrealized Carried Interest Compensation | ( | ( | |
Amortization of Intangibles | ( | ||
Transaction-related and Non-operating Items | ( | ( | |
Reimbursable Expenses | ( | ( | |
Capstone Expenses | ( | ( | |
Insurance Adjustments: | |||
Net Premiums | ( | ( | |
Policy Fees | ( | ( | |
Other Income | ( | ( | |
Non-Operating Changes in Policy Liabilities | |||
Equity-Based Compensation | ( | ( | |
Amortization of Intangibles | ( | ( | |
Transaction-Related and Non-Operating Items | ( | ( | |
Total Segment Expenses (1) | $ | $ | |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Income (Loss) Before Tax (GAAP) | $ | $ | ||
Impact of Consolidation and Other | ( | |||
Interest Expense, Net | ||||
Asset Management Adjustments: | ||||
Unrealized (Gains) Losses | ||||
Unrealized Carried Interest | ( | ( | ||
Unrealized Carried Interest Compensation | ||||
Transaction-related and Non-operating Items(1) | ||||
Equity-based Compensation | ||||
Equity-based Compensation - Performance based | ||||
Amortization of Acquired Intangibles | ||||
Strategic Holdings Adjustments: | ||||
Unrealized (Gains) Losses | ( | |||
Insurance Adjustments: | ||||
(Gains) Losses from Investments(2) | ||||
Non-Operating Changes in Policy Liabilities and Derivatives | ( | |||
Transaction-Related and Non-Operating Items(1) | ||||
Equity-Based Compensation | ||||
Amortization of Acquired Intangibles | ||||
Total Segment Earnings | $ | $ | ||
As of | |||
March 31, 2026 | March 31, 2025 | ||
Total GAAP Assets | $ | $ | |
Impact of Consolidation and Reclassifications | ( | ( | |
Carry Pool Reclassifications | ( | ( | |
Total Segment Assets | $ | $ | |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Shares of common stock repurchased | ||||
Equity awards for common stock retired | ||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Balance at the beginning of the period | $ | $ | |
Net Income (Loss) Attributable to Noncontrolling Interests | ( | ||
Other Comprehensive Income (Loss), net of tax | |||
Equity-Based Compensation (Non-Cash Contribution) | |||
Change in KKR & Co. Inc.'s Ownership Interest | ( | ( | |
Capital Contributions | |||
Capital Distributions | ( | ( | |
Changes in Consolidation | |||
Balance at the end of the period | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Balance at the beginning of the period | $ | $ | |
Net Income (Loss) Attributable to Redeemable Noncontrolling Interests | ( | ||
Capital Contributions | |||
Capital Distributions | ( | ( | |
Impact of Acquisition – Altavair (See Note 14) | |||
Balance at the end of the period | $ | $ | |









Three Months Ended March 31, | ||||
($ in millions) | 2025 | 2026 | ||
Individual Channel (1): | ||||
Retirement Products | $3,492 | $1,591 | ||
Preneed Life | 257 | 301 | ||
Institutional Channel(2)(3) | $3,664 | $1,893 | ||
By Geography | By Industry |


Adjusted Revenue(1) | Adjusted EBITDA(1) | |
$4.5 billion | $1.1 billion |
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Revenues | |||||
Asset Management and Strategic Holdings | |||||
Fees and Other | $1,186,842 | $886,810 | $300,032 | ||
Capital Allocation-Based Income (Loss) | 841,853 | 1,159,105 | (317,252) | ||
2,028,695 | 2,045,915 | (17,220) | |||
Insurance | |||||
Net Premiums | 561,970 | 323,364 | 238,606 | ||
Policy Fees | 325,694 | 338,473 | (12,779) | ||
Net Investment Income | 1,989,064 | 1,783,280 | 205,784 | ||
Net Investment-Related Gains (Losses) | (652,697) | (1,436,337) | 783,640 | ||
Other Income | 65,257 | 55,488 | 9,769 | ||
2,289,288 | 1,064,268 | 1,225,020 | |||
Total Revenues | 4,317,983 | 3,110,183 | 1,207,800 | ||
Expenses | |||||
Asset Management and Strategic Holdings | |||||
Compensation and Benefits | 1,051,681 | 1,333,103 | (281,422) | ||
Occupancy and Related Charges | 37,837 | 34,465 | 3,372 | ||
General, Administrative and Other | 381,729 | 300,332 | 81,397 | ||
1,471,247 | 1,667,900 | (196,653) | |||
Insurance | |||||
Net Policy Benefits and Claims (including market risk benefit (gain) loss of $86,338 and $221,394, respectively; remeasurement (gain) loss on policy liabilities: $— and $42,252, respectively.) | 1,880,028 | 1,708,294 | 171,734 | ||
Amortization of Policy Acquisition Costs | 142,921 | 97,971 | 44,950 | ||
Interest Expense | 73,881 | 69,571 | 4,310 | ||
Policy and Other Operating Expense | 302,058 | 287,219 | 14,839 | ||
2,398,888 | 2,163,055 | 235,833 | |||
Total Expenses | 3,870,135 | 3,830,955 | 39,180 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Investment Income (Loss) - Asset Management and Strategic Holdings | |||||
Net Gains (Losses) from Investment Activities | (316,379) | 1,086,591 | (1,402,970) | ||
Dividend Income | 268,017 | 273,890 | (5,873) | ||
Interest Income | 741,591 | 785,857 | (44,266) | ||
Interest Expense | (678,187) | (654,499) | (23,688) | ||
Total Investment Income (Loss) | 15,042 | 1,491,839 | (1,476,797) | ||
Income (Loss) Before Taxes | 462,890 | 771,067 | (308,177) | ||
Income Tax Expense (Benefit) | 185,385 | 86,569 | 98,816 | ||
Net Income (Loss) | 277,505 | 684,498 | (406,993) | ||
Net Income (Loss) Attributable to Redeemable Noncontrolling Interests | (983) | 8,494 | (9,477) | ||
Net Income (Loss) Attributable to Noncontrolling Interests | (126,741) | 861,928 | (988,669) | ||
Net Income (Loss) Attributable to KKR & Co. Inc. | 405,229 | (185,924) | 591,153 | ||
Series D Mandatory Convertible Preferred Stock Dividends | 40,430 | — | 40,430 | ||
Net Income (Loss) Attributable to KKR & Co. Inc. Common Stockholders | $364,799 | $(185,924) | $550,723 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Management Fees | $759,829 | $531,699 | $228,130 | ||
Fee Credits | (140,699) | (136,262) | (4,437) | ||
Transaction Fees | 378,083 | 388,329 | (10,246) | ||
Monitoring Fees | 59,822 | 48,671 | 11,151 | ||
Incentive Fees | 47,398 | 1,328 | 46,070 | ||
Expense Reimbursements | 55,568 | 32,208 | 23,360 | ||
Consulting Fees | 26,841 | 20,837 | 6,004 | ||
Total Fees and Other | 1,186,842 | 886,810 | 300,032 | ||
Carried Interest | 816,031 | 1,068,262 | (252,231) | ||
General Partner Capital Interest | 25,822 | 90,843 | (65,021) | ||
Total Capital Allocation-Based Income (Loss) | 841,853 | 1,159,105 | (317,252) | ||
Total Revenues | $2,028,695 | $2,045,915 | $(17,220) | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Net Premiums | $561,970 | $323,364 | $238,606 | ||
Policy Fees | 325,694 | 338,473 | (12,779) | ||
Net Investment Income | 1,989,064 | 1,783,280 | 205,784 | ||
Net Investment-Related Gains (Losses) | (652,697) | (1,436,337) | 783,640 | ||
Other Income | 65,257 | 55,488 | 9,769 | ||
Total Insurance Revenues | $2,289,288 | $1,064,268 | $1,225,020 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Equity Index Options | $(332,019) | $(339,801) | $7,782 | ||
Interest Rate Contracts | (64,847) | 174,989 | (239,836) | ||
Equity Futures Contracts | 21,109 | 28,694 | (7,585) | ||
Foreign Exchange and Other Derivative Contracts | 80,822 | (75,833) | 156,655 | ||
Funds Withheld Payable Embedded Derivatives | 279,317 | (423,563) | 702,880 | ||
Funds Withheld Receivable Embedded Derivatives | (18,830) | (24,066) | 5,236 | ||
Net Gains (Losses) on Derivative Instruments | (34,448) | (659,580) | 625,132 | ||
Net Other Investment Gains (Losses) | (618,249) | (776,757) | 158,508 | ||
Net Investment-Related Gains (Losses) | $(652,697) | $(1,436,337) | $783,640 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Realized Gains (Losses) on Investments Not Supporting Asset- Liability Matching Strategies | $— | $9,520 | $(9,520) | ||
Realized Gains (Losses) on Available-for-Sale Fixed Maturity Securities | (97,816) | (1,117,445) | 1,019,629 | ||
Credit Loss Allowances | (228,416) | (84,670) | (143,746) | ||
Unrealized Gains (Losses) on Fixed Maturity Securities Classified as Trading | (284,283) | 259,207 | (543,490) | ||
Unrealized Gains (Losses) on Other Investments Accounted Under a Fair-Value Option and Equity Investments | (42,275) | 42,075 | (84,350) | ||
Unrealized Gains (Losses) on Real Assets | (12,269) | 19,329 | (31,598) | ||
Realized Gains (Losses) on Real Assets | 16,775 | 10,501 | 6,274 | ||
Realized Gains (Losses) on Funds Withheld at Interest Payable Portfolio | 29,007 | 75,986 | (46,979) | ||
Realized Gains (Losses) on Funds Withheld at Interest Receivable Portfolio | (1,775) | (50,267) | 48,492 | ||
Foreign Exchange Gains (Losses) on Non-USD Denominated Investments | (50,308) | 76,093 | (126,401) | ||
Other | 53,111 | (17,086) | 70,197 | ||
Net Other Investment-Related Gains (Losses) | $(618,249) | $(776,757) | $158,508 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Management Fees | $1,192,504 | $917,334 | $275,170 | ||
Transaction and Monitoring Fees, Net | 252,709 | 261,509 | (8,800) | ||
Fee Related Performance Revenues | 23,762 | 21,277 | 2,485 | ||
Fee Related Compensation | (257,195) | (210,021) | (47,174) | ||
Other Operating Expenses | (195,405) | (167,496) | (27,909) | ||
Fee Related Earnings | 1,016,375 | 822,603 | 193,772 | ||
Realized Performance Income | 755,964 | 347,920 | 408,044 | ||
Realized Performance Income Compensation | (558,773) | (259,931) | (298,842) | ||
Realized Investment Income | 121,901 | 217,957 | (96,056) | ||
Realized Investment Income Compensation | (18,285) | (32,694) | 14,409 | ||
Asset Management Segment Earnings | $1,317,182 | $1,095,855 | $221,327 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Management Fees | |||||
Private Equity | $459,885 | $334,792 | $125,093 | ||
Real Assets | 383,489 | 280,578 | 102,911 | ||
Credit and Liquid Strategies | 349,130 | 301,964 | 47,166 | ||
Total Management Fees | $1,192,504 | $917,334 | $275,170 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Transaction and Monitoring Fees, Net | |||||
Private Equity | $18,636 | $18,913 | $(277) | ||
Real Assets | 7,667 | 9,855 | (2,188) | ||
Credit and Liquid Strategies | 2,759 | 3,397 | (638) | ||
Capital Markets | 223,647 | 229,344 | (5,697) | ||
Total Transaction and Monitoring Fees, Net | $252,709 | $261,509 | $(8,800) | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Fee Related Performance Revenues | |||||
Private Equity | $846 | $— | $846 | ||
Real Assets | 4,980 | 1,765 | 3,215 | ||
Credit and Liquid Strategies | 17,936 | 19,512 | (1,576) | ||
Total Fee Related Performance Revenues | $23,762 | $21,277 | $2,485 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Realized Performance Income | |||||
Private Equity | $693,643 | $334,060 | $359,583 | ||
Real Assets | 45,173 | 9,367 | 35,806 | ||
Credit and Liquid Strategies | 17,148 | 4,493 | 12,655 | ||
Total Realized Performance Income | $755,964 | $347,920 | $408,044 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Private Equity | |||||
Americas Fund XII | $241,140 | $— | $241,140 | ||
Asian Fund III | 133,327 | — | 133,327 | ||
Core Investment Vehicles | 130,169 | 187,886 | (57,717) | ||
North America Fund XI | 89,421 | — | 89,421 | ||
European Fund V | — | 89,459 | (89,459) | ||
Global Impact Fund | — | 13,215 | (13,215) | ||
Other | 99,586 | 43,500 | 56,086 | ||
Total Realized Performance Income | $693,643 | $334,060 | $359,583 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Real Assets | |||||
Crescent Energy Company | $22,387 | $— | $22,387 | ||
Real Estate Co-Investment Fund | 20,095 | — | 20,095 | ||
Global Infrastructure Investors II | — | 8,744 | (8,744) | ||
Other | 2,691 | 623 | 2,068 | ||
Total Realized Performance Income | $45,173 | $9,367 | $35,806 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Credit and Liquid Strategies | |||||
Lending Partners III | $2,236 | $— | $2,236 | ||
Alternative Credit Vehicles | — | 1,159 | (1,159) | ||
Other | 14,912 | 3,334 | 11,578 | ||
Total Realized Performance Income | $17,148 | $4,493 | $12,655 | ||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Total Realized Investment Income | $121,901 | $217,957 | $(96,056) | ||
As of | |||||
($ in millions) | March 31, 2026 | December 31, 2025 | Change | ||
Assets Under Management | $757,877 | $743,858 | $14,019 | ||
Fee Paying Assets Under Management | $614,845 | $604,144 | $10,701 | ||
Uncalled Commitments | $124,857 | $118,433 | $6,424 | ||
As of | |||||
($ in millions) | March 31, 2026 | March 31, 2025 | Change | ||
Capital Invested | $21,772 | $18,974 | $2,798 | ||
($ in millions) | |
December 31, 2025 | $229,374 |
New Capital Raised | 4,697 |
Distributions and Other | (6,517) |
Redemptions | (74) |
Change in Value | 3,567 |
March 31, 2026 | $231,047 |
($ in millions) | |
December 31, 2025 | $192,480 |
New Capital Raised | 7,805 |
Distributions and Other | (2,962) |
Redemptions | (142) |
Change in Value | 747 |
March 31, 2026 | $197,928 |
($ in millions) | |
December 31, 2025 | $322,004 |
New Capital Raised | 15,248 |
Distributions and Other | (7,286) |
Redemptions | (2,855) |
Change in Value | 1,791 |
March 31, 2026 | $328,902 |
($ in millions) | |
December 31, 2025 | $151,239 |
New Capital Raised | 5,561 |
Distributions and Other | (2,848) |
Redemptions | (74) |
Net Changes in Fee Base of Certain Funds | (438) |
Change in Value | 252 |
March 31, 2026 | $153,692 |
($ in millions) | |
December 31, 2025 | $163,451 |
New Capital Raised | 7,959 |
Distributions and Other | (2,136) |
Redemptions | (142) |
Change in Value | (311) |
March 31, 2026 | $168,821 |
($ in millions) | |
December 31, 2025 | $289,454 |
New Capital Raised | 12,518 |
Distributions and Other | (8,438) |
Redemptions | (2,855) |
Change in Value | 1,653 |
March 31, 2026 | $292,332 |
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Net Investment Income | $1,900,612 | $1,729,343 | $171,269 | ||
Net Cost of Insurance | (1,453,334) | (1,287,983) | (165,351) | ||
General, Administrative and Other | (186,948) | (182,588) | (4,360) | ||
Insurance Operating Earnings | $260,330 | $258,772 | $1,558 | ||
Three Months Ended | ||||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | |||
Dividends, Net | $48,296 | $31,486 | $16,810 | |||
Strategic Holdings Operating Earnings | 48,296 | 31,486 | 16,810 | |||
Net Realized Investment Income | — | — | — | |||
Strategic Holdings Segment Earnings | $48,296 | $31,486 | $16,810 | |||
Three Months Ended | |||||
($ in thousands) | March 31, 2026 | March 31, 2025 | Change | ||
Fee Related Earnings | $1,016,375 | $822,603 | $193,772 | ||
Insurance Operating Earnings | 260,330 | 258,772 | 1,558 | ||
Strategic Holdings Operating Earnings | 48,296 | 31,486 | 16,810 | ||
Total Operating Earnings | 1,325,001 | 1,112,861 | 212,140 | ||
Net Realized Performance Income | 197,191 | 87,989 | 109,202 | ||
Net Realized Investment Income | 103,616 | 185,263 | (81,647) | ||
Total Investing Earnings | 300,807 | 273,252 | 27,555 | ||
Total Segment Earnings | 1,625,808 | 1,386,113 | 239,695 | ||
Interest Expense, Net and Other | (128,304) | (91,470) | (36,834) | ||
Income Taxes on Adjusted Earnings | (247,965) | (260,655) | 12,690 | ||
Adjusted Net Income | $1,249,539 | $1,033,988 | $215,551 | ||
Investment Period | Amount ($ in millions) | |||||||||
Start Date(1) | End Date (2) | Commitment (3) | Uncalled Commitments | Invested | Realized | Remaining Cost (4) | Remaining Fair Value | Gross Accrued Carried Interest | ||
Private Equity Business Line | ||||||||||
North America Fund XIV | 4/2025 | 4/2031 | $21,893 | $21,893 | $— | $— | $— | $— | $— | |
North America Fund XIII | 8/2021 | 4/2025 | 18,400 | 1,432 | 17,271 | 566 | 16,786 | 23,446 | 1,062 | |
Americas Fund XII | 5/2017 | 5/2021 | 13,500 | 1,386 | 12,754 | 18,506 | 7,873 | 16,320 | 1,442 | |
North America Fund XI | 11/2012 | 1/2017 | 8,718 | 48 | 10,203 | 25,152 | 1,172 | 1,707 | 190 | |
2006 Fund (5) | 9/2006 | 9/2012 | 17,642 | — | 17,309 | 37,423 | — | — | — | |
Millennium Fund (5) | 12/2002 | 12/2008 | 6,000 | — | 6,000 | 14,129 | — | — | — | |
Ascendant Fund | 6/2022 | 6/2028 | 4,328 | 2,194 | 2,134 | — | 2,134 | 2,511 | 32 | |
European Fund VI | 6/2022 | 6/2028 | 7,521 | 2,537 | 4,984 | — | 3,888 | 5,749 | — | |
European Fund V | 7/2019 | 2/2022 | 6,379 | 505 | 5,997 | 2,909 | 4,552 | 6,640 | 390 | |
European Fund IV | 2/2015 | 3/2019 | 3,512 | 16 | 3,648 | 5,726 | 1,621 | 2,187 | 96 | |
European Fund III (5) | 3/2008 | 3/2014 | 5,506 | — | 5,360 | 10,647 | — | — | — | |
European Fund II (5) | 11/2005 | 10/2008 | 5,751 | — | 5,751 | 8,533 | — | — | — | |
Asian Fund IV | 7/2020 | 7/2026 | 14,735 | 3,857 | 12,061 | 4,229 | 11,108 | 16,204 | 954 | |
Asian Fund III | 8/2017 | 7/2020 | 9,000 | 1,267 | 8,274 | 11,601 | 4,628 | 8,680 | 884 | |
Asian Fund II | 10/2013 | 3/2017 | 5,825 | — | 7,507 | 6,723 | 1,270 | 744 | — | |
Asian Fund (5) | 7/2007 | 4/2013 | 3,983 | — | 3,974 | 8,728 | — | — | — | |
Next Generation Technology Growth Fund III | 11/2022 | 3/2026 | 2,740 | 734 | 2,006 | — | 2,006 | 2,302 | — | |
Next Generation Technology Growth Fund II | 12/2019 | 5/2022 | 2,088 | 53 | 2,270 | 1,846 | 1,610 | 2,390 | 137 | |
Next Generation Technology Growth Fund | 3/2016 | 12/2019 | 659 | 2 | 671 | 1,314 | 241 | 871 | 66 | |
Health Care Strategic Growth Fund II | 5/2021 | 5/2027 | 3,789 | 1,421 | 2,368 | 103 | 2,245 | 3,556 | 177 | |
Health Care Strategic Growth Fund | 12/2016 | 4/2021 | 1,331 | 86 | 1,409 | 1,085 | 987 | 1,674 | 130 | |
Global Impact Fund II | 6/2022 | 6/2028 | 2,711 | 1,374 | 1,337 | — | 986 | 3,237 | 340 | |
Global Impact Fund | 2/2019 | 3/2022 | 1,242 | 187 | 1,238 | 646 | 975 | 1,450 | 92 | |
Co-Investment Vehicles and Other | Various | Various | 43,072 | 3,430 | 40,360 | 18,205 | 30,328 | 37,711 | 1,844 | |
Core Investors II | 8/2022 | 8/2027 | 11,814 | 7,957 | 3,858 | 122 | 3,858 | 4,495 | (22) | |
Core Investors I | 2/2018 | 8/2022 | 8,500 | 23 | 10,501 | 2,683 | 8,767 | 17,525 | (21) | |
Other Core Vehicles | Various | Various | 7,625 | 1,175 | 6,526 | 2,313 | 5,787 | 9,356 | 11 | |
Unallocated Commitments (6) | N/A | N/A | 1,684 | 1,684 | — | — | — | — | — | |
Total Private Equity | $239,948 | $53,261 | $195,771 | $183,189 | $112,822 | $168,755 | $7,804 | |||
Investment Period | Amount ($ in millions) | |||||||||
Start Date (1) | End Date (2) | Commitment (3) | Uncalled Commitments | Invested | Realized | Remaining Cost (4) | Remaining Fair Value | Gross Accrued Carried Interest | ||
Real Assets Business Line | ||||||||||
Global Infrastructure Investors V | 7/2024 | 7/2030 | $17,295 | $13,613 | $3,795 | $113 | $3,795 | $4,033 | $14 | |
Global Infrastructure Investors IV | 8/2021 | 6/2024 | 16,609 | 1,731 | 15,249 | 1,703 | 14,554 | 19,620 | 1,030 | |
Global Infrastructure Investors III | 7/2018 | 6/2021 | 7,174 | 467 | 7,073 | 5,828 | 3,718 | 5,153 | 215 | |
Global Infrastructure Investors II | 12/2014 | 6/2018 | 3,040 | 133 | 3,167 | 5,764 | 560 | 961 | 48 | |
Global Infrastructure Investors | 9/2010 | 10/2014 | 1,040 | — | 1,050 | 2,228 | — | — | — | |
Asia Pacific Infrastructure Investors III | 12/2025 | 12/2031 | 4,473 | 4,473 | — | — | — | — | — | |
Asia Pacific Infrastructure Investors II | 9/2022 | 9/2028 | 6,348 | 3,117 | 3,633 | 797 | 2,943 | 4,330 | 262 | |
Asia Pacific Infrastructure Investors | 1/2020 | 9/2022 | 3,792 | 592 | 3,562 | 2,286 | 2,213 | 3,097 | 197 | |
Diversified Core Infrastructure Fund | 12/2020 | (5) | 14,343 | 1,959 | 12,384 | 1,723 | 12,265 | 13,512 | — | |
Global Climate Transition Fund(6) | 7/2024 | 7/2030 | 3,128 | 3,128 | — | — | — | — | — | |
Real Estate Partners Americas IV | 11/2024 | 11/2028 | 2,272 | 2,272 | — | — | — | — | — | |
Real Estate Partners Americas III | 1/2021 | 9/2024 | 4,253 | 523 | 3,979 | 379 | 3,713 | 4,246 | — | |
Real Estate Partners Americas II | 5/2017 | 12/2020 | 1,921 | 116 | 1,988 | 3,094 | 137 | 57 | 1 | |
Real Estate Partners Americas | 5/2013 | 5/2017 | 1,229 | 15 | 1,024 | 1,444 | — | — | (4) | |
Real Estate Partners Europe II | 3/2020 | 12/2023 | 2,066 | 238 | 2,032 | 625 | 1,654 | 1,447 | — | |
Real Estate Partners Europe | 8/2015 | 12/2019 | 710 | 99 | 694 | 806 | 173 | 81 | (18) | |
Asia Real Estate Partners | 7/2019 | 7/2023 | 1,682 | 353 | 1,380 | 617 | 971 | 864 | — | |
Property Partners Americas | 12/2019 | (5) | 2,571 | 46 | 2,525 | 179 | 2,525 | 2,304 | — | |
Real Estate Credit Opportunity Partners II | 8/2019 | 6/2023 | 950 | — | 976 | 487 | 855 | 869 | 29 | |
Real Estate Credit Opportunity Partners | 2/2017 | 4/2019 | 1,130 | 122 | 1,008 | 697 | 964 | 1,002 | 5 | |
Energy Related Vehicles | Various | Various | 4,357 | 62 | 4,493 | 2,543 | 954 | 1,584 | 58 | |
Co-Investment Vehicles & Other | Various | Various | 21,037 | 2,070 | 19,027 | 4,668 | 16,915 | 17,985 | 131 | |
Unallocated Commitments(7) | N/A | N/A | 1,384 | 1,384 | — | — | — | — | — | |
Total Real Assets | $122,804 | $36,513 | $89,039 | $35,981 | $68,909 | $81,145 | $1,968 | |||
Private Equity and Real Assets Business Lines Investment Funds and Other Vehicles | Commitment (2) | Invested | Realized (4) | Unrealized | Total Value | Gross IRR (5) | Net IRR (5) | Gross Multiple of Invested Capital (5) | |||
($ in millions) | |||||||||||
Total Investments | |||||||||||
Legacy Funds (1) | |||||||||||
1976 Fund | $31 | $31 | $537 | $— | $537 | 39.5% | 35.5% | 17.1 | |||
1980 Fund | 357 | 357 | 1,828 | — | 1,828 | 29.0% | 25.8% | 5.1 | |||
1982 Fund | 328 | 328 | 1,291 | — | 1,291 | 48.1% | 39.2% | 3.9 | |||
1984 Fund | 1,000 | 1,000 | 5,964 | — | 5,964 | 34.5% | 28.9% | 6.0 | |||
1986 Fund | 672 | 672 | 9,081 | — | 9,081 | 34.4% | 28.9% | 13.5 | |||
1987 Fund | 6,130 | 6,130 | 14,949 | — | 14,949 | 12.1% | 8.9% | 2.4 | |||
1993 Fund | 1,946 | 1,946 | 4,143 | — | 4,143 | 23.6% | 16.8% | 2.1 | |||
1996 Fund | 6,012 | 6,012 | 12,477 | — | 12,477 | 18.0% | 13.3% | 2.1 | |||
Subtotal - Legacy Funds | 16,475 | 16,475 | 50,269 | — | 50,269 | 26.1% | 19.9% | 3.1 | |||
Included Funds | |||||||||||
European Fund (1999) | 3,085 | 3,085 | 8,758 | — | 8,758 | 26.9% | 20.2% | 2.8 | |||
Millennium Fund (2002) | 6,000 | 6,000 | 14,129 | — | 14,129 | 22.0% | 16.1% | 2.4 | |||
European Fund II (2005) | 5,751 | 5,751 | 8,533 | — | 8,533 | 6.1% | 4.5% | 1.5 | |||
2006 Fund (2006) | 17,642 | 17,309 | 37,423 | — | 37,423 | 11.9% | 9.3% | 2.2 | |||
Asian Fund (2007) | 3,983 | 3,974 | 8,728 | — | 8,728 | 18.9% | 13.7% | 2.2 | |||
European Fund III (2008) | 5,506 | 5,360 | 10,647 | — | 10,647 | 16.4% | 11.2% | 2.0 | |||
E2 Investors (Annex Fund) (2009) | 196 | 196 | 200 | — | 200 | 0.6% | 0.5% | 1.0 | |||
China Growth Fund (2010) | 1,010 | 1,010 | 1,166 | — | 1,166 | 3.7% | —% | 1.2 | |||
Natural Resources Fund (2010) | 887 | 887 | 168 | — | 168 | (24.3)% | (25.9)% | 0.2 | |||
Global Infrastructure Investors (2010) | 1,040 | 1,050 | 2,228 | — | 2,228 | 17.6% | 15.6% | 2.1 | |||
North America Fund XI (2012) | 8,718 | 10,203 | 25,152 | 1,707 | 26,859 | 23.4% | 18.8% | 2.6 | |||
Asian Fund II (2013) | 5,825 | 7,507 | 6,723 | 744 | 7,467 | (0.2)% | (1.6)% | 1.0 | |||
Real Estate Partners Americas (2013) | 1,229 | 1,024 | 1,444 | — | 1,444 | 15.8% | 10.9% | 1.4 | |||
Energy Income and Growth Fund (2013) | 1,589 | 1,589 | 1,221 | — | 1,221 | (6.2)% | (8.6)% | 0.8 | |||
Global Infrastructure Investors II (2014) | 3,040 | 3,167 | 5,764 | 961 | 6,725 | 19.2% | 16.6% | 2.1 | |||
European Fund IV (2015) | 3,512 | 3,648 | 5,726 | 2,187 | 7,913 | 20.6% | 15.5% | 2.2 | |||
Real Estate Partners Europe (2015) | 710 | 694 | 806 | 81 | 887 | 8.6% | 5.7% | 1.3 | |||
Next Generation Technology Growth Fund (2016) | 659 | 671 | 1,314 | 871 | 2,185 | 27.7% | 23.5% | 3.3 | |||
Health Care Strategic Growth Fund (2016) | 1,331 | 1,409 | 1,085 | 1,674 | 2,759 | 17.0% | 12.3% | 2.0 | |||
Americas Fund XII (2017) | 13,500 | 12,754 | 18,506 | 16,320 | 34,826 | 23.4% | 19.5% | 2.7 | |||
Real Estate Credit Opportunity Partners (2017) | 1,130 | 1,008 | 697 | 1,002 | 1,699 | 9.1% | 7.8% | 1.7 | |||
Core Investors I (2018) | 8,500 | 10,501 | 2,683 | 17,525 | 20,208 | 14.0% | 12.4% | 1.9 | |||
Asian Fund III (2017) | 9,000 | 8,274 | 11,601 | 8,680 | 20,281 | 23.7% | 18.5% | 2.5 | |||
Real Estate Partners Americas II (2017) | 1,921 | 1,988 | 3,094 | 57 | 3,151 | 23.8% | 19.2% | 1.6 | |||
Global Infrastructure Investors III (2018) | 7,174 | 7,073 | 5,828 | 5,153 | 10,981 | 12.4% | 9.7% | 1.6 | |||
Global Impact Fund (2019) | 1,242 | 1,238 | 646 | 1,450 | 2,096 | 14.8% | 10.6% | 1.7 | |||
European Fund V (2019) | 6,379 | 5,997 | 2,909 | 6,640 | 9,549 | 12.2% | 9.5% | 1.6 | |||
Energy Income and Growth Fund II (2018) | 994 | 1,199 | 689 | 1,419 | 2,108 | 14.0% | 12.4% | 1.8 | |||
Asia Real Estate Partners (2019) | 1,682 | 1,380 | 617 | 864 | 1,481 | 2.4% | (0.5)% | 1.1 | |||
Next Generation Technology Growth Fund II (2019) | 2,088 | 2,270 | 1,846 | 2,390 | 4,236 | 18.2% | 14.3% | 1.9 | |||
Real Estate Credit Opportunity Partners II (2019) | 950 | 976 | 487 | 869 | 1,356 | 9.9% | 7.7% | 1.4 | |||
Asia Pacific Infrastructure Investors (2020) | 3,792 | 3,562 | 2,286 | 3,097 | 5,383 | 15.4% | 11.5% | 1.5 | |||
Asian Fund IV (2020) | 14,735 | 12,061 | 4,229 | 16,204 | 20,433 | 23.3% | 17.5% | 1.7 | |||
Real Estate Partners Europe II (2020) | 2,066 | 2,032 | 625 | 1,447 | 2,072 | 0.7% | (1.5)% | 1.0 | |||
Real Estate Partners Americas III (2021) | 4,253 | 3,979 | 379 | 4,246 | 4,625 | 5.2% | 3.4% | 1.2 | |||
Health Care Strategic Growth Fund II (2021) | 3,789 | 2,368 | 103 | 3,556 | 3,659 | 24.4% | 15.7% | 1.5 | |||
North America Fund XIII (2021) | 18,400 | 17,271 | 566 | 23,446 | 24,012 | 15.0% | 11.3% | 1.4 | |||
Global Infrastructure Investors IV (2021) | 16,609 | 15,249 | 1,703 | 19,620 | 21,323 | 13.8% | 10.6% | 1.4 | |||
Core Investors II (2022) | 11,814 | 3,858 | 122 | 4,495 | 4,617 | 8.3% | 7.4% | 1.2 | |||
Asia Pacific Infrastructure Investors II (2022) | 6,348 | 3,633 | 797 | 4,330 | 5,127 | 28.4% | 20.7% | 1.4 | |||
Ascendant Fund (2022) | 4,328 | 2,134 | — | 2,511 | 2,511 | 18.5% | 8.5% | 1.2 | |||
Next Generation Technology Growth Fund III (2022) | 2,740 | 2,006 | — | 2,302 | 2,302 | 11.3% | 4.8% | 1.1 | |||
European Fund VI (2022) | 7,521 | 4,984 | — | 5,749 | 5,749 | 9.3% | 5.7% | 1.2 | |||
Global Impact Fund II (2022) | 2,711 | 1,337 | — | 3,237 | 3,237 | 63.1% | 46.2% | 2.4 | |||
Global Infrastructure Investors V (2024) (3) | 17,295 | 3,795 | 113 | 4,033 | 4,146 | —% | —% | — | |||
Global Climate Transition Fund (2024) (3) | 3,128 | — | — | — | — | —% | —% | — | |||
Real Estate Partners Americas IV (2024) (3) | 2,272 | — | — | — | — | —% | —% | — | |||
North America Fund XIV (2025)(3) | 21,893 | — | — | — | — | —% | —% | — | |||
Asia Pacific Infrastructure Investors III (2025)(3) | 4,473 | — | — | — | — | —% | —% | — | |||
Subtotal - Included Funds | 274,440 | 207,461 | 201,741 | 168,867 | 370,608 | 15.7% | 12.0% | 1.8 | |||
All Funds | $290,915 | $223,936 | $252,010 | $168,867 | $420,877 | 25.5% | 18.5% | 1.9 | |||
Investment Period | Amount ($ in millions) | ||||||||
Start Date (1) | End Date (2) | Commitment (3) | Uncalled Commitments | Invested | Realized | Remaining Cost (4) | Remaining Fair Value | Gross Accrued Carried Interest | |
Credit and Liquid Strategies Business Line | |||||||||
Opportunities Fund II | 11/2021 | 1/2026 | $2,420 | $897 | $1,427 | $291 | $1,302 | $1,598 | $53 |
Dislocation Opportunities Fund | 8/2019 | 11/2021 | 2,967 | 268 | 2,522 | 1,866 | 1,292 | 1,310 | 69 |
Special Situations Fund II | 2/2015 | 3/2019 | 3,525 | 284 | 3,241 | 2,651 | 615 | 640 | — |
Special Situations Fund | 1/2013 | 1/2016 | 2,274 | 1 | 2,273 | 1,899 | 94 | 138 | — |
Mezzanine Partners | 7/2010 | 3/2015 | 1,023 | 33 | 990 | 1,166 | 184 | 2 | — |
Asset-Based Finance Partners II | 3/2024 | 3/2028 | 5,571 | 4,420 | 1,151 | — | 1,151 | 1,242 | 12 |
Asset-Based Finance Partners | 10/2020 | 7/2025 | 2,059 | 385 | 1,674 | 627 | 1,493 | 1,619 | 81 |
Private Credit Opportunities Partners II | 12/2015 | 12/2020 | 2,245 | 188 | 2,057 | 1,089 | 1,264 | 1,117 | — |
Lending Partners IV | 3/2022 | 9/2026 | 1,150 | 173 | 977 | 201 | 977 | 1,001 | 15 |
Lending Partners III | 4/2017 | 11/2021 | 1,498 | 540 | 958 | 1,247 | 390 | 338 | 30 |
Lending Partners II | 6/2014 | 6/2017 | 1,336 | 157 | 1,179 | 1,276 | — | 3 | — |
Lending Partners | 12/2011 | 12/2014 | 460 | 40 | 420 | 466 | — | 1 | — |
Lending Partners Europe II | 5/2019 | 9/2023 | 837 | 159 | 678 | 792 | 193 | 199 | 9 |
Lending Partners Europe | 3/2015 | 3/2019 | 848 | 184 | 662 | 632 | 53 | 49 | — |
Asia Credit Opportunities II | 2/2025 | 12/2028 | 1,795 | 1,604 | 191 | — | 191 | 186 | — |
Asia Credit Opportunities | 1/2021 | 5/2025 | 1,084 | 197 | 887 | 330 | 713 | 866 | 42 |
Other Alternative Credit Vehicles | Various | Various | 19,037 | 8,191 | 10,898 | 7,427 | 5,738 | 7,136 | (9) |
Total Credit and Liquid Strategies | $50,129 | $17,721 | $32,185 | $21,960 | $15,650 | $17,445 | $302 | ||
Leveraged Credit Strategy | Inception Date | Gross Returns | Net Returns | Benchmark (1) | Benchmark Gross Returns | |||||
Multi-Asset Credit Composite | Jul 2008 | 7.04% | 6.35% | 50% S&P/LSTA Loan Index, 50% BoAML HY Master II Index (2) | 5.77% | |||||
Opportunistic Credit (3) | May 2008 | 10.17% | 8.69% | 50% S&P/LSTA Loan Index, 50% BoAML HY Master II Index (3) | 5.94% | |||||
Bank Loans | Apr 2011 | 5.77% | 5.20% | S&P/LSTA Loan Index (4) | 4.81% | |||||
High-Yield | Apr 2011 | 6.21% | 5.63% | BoAML HY Master II Index (5) | 5.60% | |||||
European Leveraged Loans (6) | Sep 2009 | 4.81% | 4.29% | CS Inst West European Leveraged Loan Index (7) | 3.93% | |||||
European Credit Opportunities (6) | Sept 2007 | 6.84% | 5.61% | S&P European Leveraged Loans (All Loans) (8) | 4.50% |
Credit and Liquid Strategies Investment Funds | Investment Period Start Date | Commitment | Invested (1) | Realized (1) | Unrealized | Total Value | Gross IRR (2) | Net IRR (2) | Multiple of Invested Capital (3) | |||||||||
($ in Millions) | ||||||||||||||||||
Opportunities Fund II | Nov 2021 | $2,420 | $1,427 | $291 | $1,598 | $1,889 | 16.4% | 12.5% | 1.3 | |||||||||
Dislocation Opportunities Fund | Aug 2019 | 2,967 | 2,522 | 1,866 | 1,310 | 3,176 | 8.4% | 6.4% | 1.3 | |||||||||
Special Situations Fund II | Feb 2015 | 3,525 | 3,241 | 2,651 | 640 | 3,291 | 0.3% | (1.4)% | 1.0 | |||||||||
Special Situations Fund | Jan 2013 | 2,274 | 2,273 | 1,899 | 138 | 2,037 | (2.3)% | (4.1)% | 0.9 | |||||||||
Mezzanine Partners | July 2010 | 1,023 | 990 | 1,166 | 2 | 1,168 | 6.5% | 2.7% | 1.2 | |||||||||
Asset-Based Finance Partners II | Mar 2024 | 5,571 | 1,151 | — | 1,242 | 1,242 | 13.1% | 9.0% | 1.1 | |||||||||
Asset-Based Finance Partners | Oct 2020 | 2,059 | 1,674 | 627 | 1,619 | 2,246 | 13.9% | 10.4% | 1.3 | |||||||||
Private Credit Opportunities Partners II | Dec 2015 | 2,245 | 2,057 | 1,089 | 1,117 | 2,206 | 1.6% | (0.1)% | 1.1 | |||||||||
Lending Partners IV | Mar 2022 | 1,150 | 977 | 201 | 1,001 | 1,202 | 15.0% | 11.8% | 1.2 | |||||||||
Lending Partners III | Apr 2017 | 1,498 | 958 | 1,247 | 338 | 1,585 | 13.7% | 11.2% | 1.7 | |||||||||
Lending Partners II | Jun 2014 | 1,336 | 1,179 | 1,276 | 3 | 1,279 | 2.8% | 1.4% | 1.1 | |||||||||
Lending Partners | Dec 2011 | 460 | 420 | 466 | 1 | 467 | 3.2% | 1.6% | 1.1 | |||||||||
Lending Partners Europe II | May 2019 | 837 | 678 | 792 | 199 | 991 | 16.6% | 13.3% | 1.5 | |||||||||
Lending Partners Europe | Mar 2015 | 848 | 662 | 632 | 49 | 681 | 0.9% | (0.9)% | 1.0 | |||||||||
Asia Credit Opportunities II | Feb 2025 | 1,795 | 191 | — | 186 | 186 | N/A | N/A | 1.0 | |||||||||
Asia Credit Opportunities | Jan 2021 | 1,084 | 887 | 330 | 866 | 1,196 | 14.6% | 11.1% | 1.3 | |||||||||
Other Alternative Credit Vehicles | Various | 19,037 | 10,898 | 7,427 | 7,136 | 14,563 | N/A | N/A | N/A | |||||||||
All Funds | $50,129 | $32,185 | $21,960 | $17,445 | $39,405 | |||||||||||||
As of March 31, 2026 | ||||||
Asset Management Segment Investments (1) | Cost | Fair Value | Fair Value as a Percentage of Total Asset Management Investments | |||
($ in thousands) | ||||||
Traditional Private Equity | $1,474,950 | $3,243,448 | 41% | |||
Growth Equity | 269,737 | 1,019,211 | 13% | |||
Private Equity Total | 1,744,687 | 4,262,659 | 54% | |||
Real Estate | 1,488,172 | 1,243,305 | 16% | |||
Infrastructure | 289,734 | 547,007 | 7% | |||
Energy | 31,946 | 343,207 | 4% | |||
Real Assets Total | 1,809,852 | 2,133,519 | 27% | |||
Alternative Credit | 498,078 | 582,830 | 7% | |||
Leveraged Credit | 479,349 | 390,088 | 5% | |||
Credit Total | 977,427 | 972,918 | 12% | |||
Other | 692,495 | 629,967 | 7% | |||
Total Asset Management Segment Investments | $5,224,461 | $7,999,063 | 100% | |||
($ in thousands) | As of March 31, 2026 | December 31, 2025 | ||||||
Fixed-maturity securities, available-for-sale | $92,067,828 | 47% | $95,672,043 | 48% | ||||
Mortgage and other loan receivables | 52,779,605 | 27% | 53,638,617 | 27% | ||||
Fixed-maturity securities, trading | 26,670,358 | 14% | 26,419,591 | 13% | ||||
Real assets | 15,401,351 | 8% | 15,369,758 | 8% | ||||
Other investments | 8,041,000 | 4% | 6,936,028 | 3% | ||||
Funds withheld receivables, at interest | 2,267,167 | 1% | 2,324,346 | 1% | ||||
Total investments | $197,227,309 | $200,360,383 | ||||||
Three Months Ended | |||
($ in thousands) | March 31, 2026 | March 31, 2025 | |
Net Income (Loss) - KKR Common Stockholders (GAAP) | $364,799 | $(185,924) | |
Preferred Stock Dividends | 40,430 | — | |
Net Income (Loss) Attributable to Noncontrolling Interests | (127,724) | 870,422 | |
Income Tax Expense (Benefit) | 185,385 | 86,569 | |
Income (Loss) Before Tax (GAAP) | $462,890 | $771,067 | |
Impact of Consolidation and Other | 53,946 | (1,017,351) | |
Preferred Stock Dividends | (40,430) | — | |
Income Taxes on Adjusted Earnings | (247,965) | (260,655) | |
Asset Management Adjustments: | |||
Unrealized (Gains) Losses | 177,131 | 379,337 | |
Unrealized Carried Interest | (9,664) | (807,713) | |
Unrealized Carried Interest Compensation | 7,733 | 646,170 | |
Transaction-related and Non-operating Items(1) | 34,009 | 10,551 | |
Equity-based Compensation(2) | 68,396 | 78,277 | |
Equity-based Compensation - Performance based(2) | 82,319 | 84,599 | |
Amortization of Acquired Intangibles | 3,168 | — | |
Strategic Holdings Adjustments: | |||
Unrealized (Gains) Losses | 120,613 | (321,408) | |
Insurance Adjustments: | |||
(Gains) Losses from Investments | 508,943 | 1,358,940 | |
Non-Operating Changes in Policy Liabilities and Derivatives | (26,058) | 86,631 | |
Transaction-Related and Non-Operating Items(1) | 13,961 | 152 | |
Equity-Based Compensation | 26,360 | 20,692 | |
Amortization of Acquired Intangibles | 14,187 | 4,699 | |
Adjusted Net Income | $1,249,539 | $1,033,988 | |
Interest Expense, Net | 83,011 | 74,509 | |
Preferred Stock Dividends | 40,430 | 13,477 | |
Net Income Attributable to Noncontrolling Interests | 4,863 | 3,484 | |
Income Taxes on Adjusted Earnings | 247,965 | 260,655 | |
Total Segment Earnings | $1,625,808 | $1,386,113 | |
Net Realized Performance Income | (197,191) | (87,989) | |
Net Realized Investment Income | (103,616) | (185,263) | |
Total Operating Earnings | $1,325,001 | $1,112,861 | |
Total Investing Earnings | 300,807 | 273,252 | |
Depreciation and Amortization | 20,547 | 13,233 | |
Adjusted EBITDA | $1,646,355 | $1,399,346 | |
As of | |
($ in thousands) | March 31, 2026 |
($ in thousands) | |
KKR & Co. Inc. Stockholders' Equity - Common Stock (GAAP) | $27,952,749 |
Impact of Consolidation and Other | 330,118 |
Exchangeable Securities | 367,286 |
Accumulated Other Comprehensive (Income) Loss (AOCI) and Other (Insurance) | 4,701,127 |
Accumulated Unrealized (Gains) Losses on Loans carried at Fair Value (Insurance) | (104,073) |
KKR Book Value(1) | $33,247,207 |
As of | |
($ in thousands) | March 31, 2026 |
Cash and Cash Equivalents - Asset Management and Strategic Holdings (GAAP) | $9,273,480 |
Impact of Consolidation and Other | (4,587,552) |
Short-term Investments | 281,697 |
Cash and Short-term Investments | $4,967,625 |
As of | |
($ in thousands) | March 31, 2026 |
Investments - Asset Management and Strategic Holdings (GAAP) | $128,050,466 |
Impact of Consolidation and Other | (119,769,705) |
Short-term Investments | (281,697) |
Investments - Asset Management Segment | $7,999,064 |
As of March 31, 2026 | ||||
($ in thousands) | Fixed-Indexed Annuity | Other | ||
Balance | $1,159,749 | $222,803 | ||
Hypothetical Change: | ||||
+50 bps Interest Rates | (154,125) | (35,341) | ||
-50 bps Interest Rates | 171,258 | 38,991 | ||
+50 bps Instrument-specific Credit Risk | (155,321) | (18,863) | ||
-50 bps Instrument-specific Credit Risk | 171,746 | 20,496 | ||
+10% Equity Market Prices | (73,824) | (32,485) | ||
-10% Equity Market Prices | 52,339 | 35,574 | ||
95% of Expected Mortality | 63,458 | 4,086 | ||
105% of Expected Mortality | (59,687) | (3,546) | ||
90% of Expected Surrenders | 31,453 | 1,437 | ||
110% of Expected Surrenders | (29,977) | (1,414) | ||
As of March 31, 2026 | ||
($ in thousands) | Variable Annuities | |
Balance | $254,107 | |
Hypothetical Change: | ||
+50 bps Interest Rates | (16,475) | |
-50 bps Interest Rates | 17,810 | |
+50 bps Instrument-specific Credit Risk | (10,032) | |
-50 bps Instrument-specific Credit Risk | 10,379 | |
+10% Equity Market Prices | (13,470) | |
-10% Equity Market Prices | 16,044 | |
95% of Expected Mortality | (4,695) | |
105% of Expected Mortality | 4,494 | |
90% of Expected Surrenders | 105 | |
110% of Expected Surrenders | (131) |
As of March 31, 2026 | ||||
($ in thousands) | Payout Annuities | Other | ||
Balance | $12,523,843 | $1,683,664 | ||
Hypothetical Change: | ||||
+50 bps Interest Rates | (217,890) | (470,702) | ||
-50 bps Interest Rates | 233,752 | 507,260 | ||
+50 bps Credit Spreads | (165,764) | (356,480) | ||
-50 bps Credit Spreads | 171,753 | 370,947 | ||
95% of Expected Mortality(1) | 77,728 | 40,664 | ||
105% of Expected Mortality(1) | (73,821) | (38,668) | ||
90% of Expected Surrenders/Lapses | — | (10,910) | ||
110% of Expected Surrenders/Lapses | — | 9,935 | ||
As of March 31, 2026 | ||
($ in thousands) | Interest-Sensitive Life | |
Balance | $6,225,044 | |
Hypothetical Change: | ||
+50 bps Interest Rates | 1,728 | |
-50 bps Interest Rates | (1,742) | |
+10% Equity Market Prices | (1,315) | |
-10% Equity Market Prices | 635 | |
1% Lower Annual Equity Growth | 7,196 | |
95% of Expected Mortality | (53,273) | |
105% of Expected Mortality | 52,461 | |
90% of Expected Surrenders | 23,413 | |
110% of Expected Surrenders | (22,919) |
As of March 31, 2026 | ||||
($ in thousands) | Fixed-Indexed Annuities | Interest Sensitive Life | ||
Balance | $7,037,204 | $434,567 | ||
Hypothetical Change: | ||||
+50 bps Interest Rates | (106,516) | (4,695) | ||
-50 bps Interest Rates | 111,831 | 4,889 | ||
+50 bps Credit Spreads | (136,153) | (4,695) | ||
-50 bps Credit Spreads | 141,010 | 4,889 | ||
+10% Equity Market Prices | 781,693 | 36,893 | ||
-10% Equity Market Prices | (718,536) | (63,296) | ||
As of March 31, 2026 | ||||
($ in thousands) | Embedded Derivative on Funds Withheld Receivable | Embedded Derivative on Funds Withheld Payable | ||
Balance | $60,028 | $(2,555,171) | ||
Hypothetical Change: | ||||
+50 bps Interest Rates | (4,152) | (1,434,048) | ||
-50 bps Interest Rates | 9,127 | 1,519,163 | ||
+50 bps Investment Credit Spreads | (42,276) | (1,495,984) | ||
-50 bps Investment Credit Spreads | 42,276 | 1,581,099 | ||
Issuer Purchases of Common Stock | |||||||
(amounts in thousands, except share and per share amounts) | |||||||
Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1) | ||||
Month #1 (January 1, 2026 to January 31, 2026) | — | $— | — | $439,178 | |||
Month #2 (February 1, 2026 to February 28, 2026) | 21,598 | $92.60 | 21,598 | $437,133 | |||
Month #3 (March 1, 2026 to March 31, 2026) | 2,152,372 | $87.92 | 2,152,372 | $247,877 | |||
Total through March 31, 2026 | 2,173,970 | 2,173,970 | $247,877 | ||||
Exhibit No. | Description of Exhibit | |
3.1 | Second Amended and Restated Certificate of Incorporation of KKR & Co. Inc. (incorporated by reference to Exhibit 3.1 to the KKR & Co. Inc. Current Report on Form 8-K filed on August 9, 2024). | |
3.2 | Second Amended and Restated Bylaws of KKR & Co. Inc. (incorporated by reference to Exhibit 3.2 to the KKR & Co. Inc. Current Report on Form 8-K filed on August 9, 2024). | |
10.1 † | Credit Agreement, dated as of January 16, 2026, among Global Atlantic Limited (Delaware), Global Atlantic (Fin) Company, the borrowers party thereto, the lenders from time to time party thereto, Wells Fargo Bank, N.A., as administrative agent, and the other agents and arrangers party thereto (incorporated by reference to Exhibit 10.28 to the KKR & Co. Inc. Annual Report on Form 10-K filed on February 27, 2026). | |
31.1 | Certification of Co-Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002. | |
31.2 | Certification of Co-Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.3 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1 | Certification of Co-Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2 | Certification of Co-Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.3 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101 | Interactive data files pursuant to Rule 405 of Regulation S-T, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Financial Condition as of March 31, 2026 and December 31, 2025, (ii) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and March 31, 2025, (iii) the Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and March 31, 2025; (iv) the Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2026 and March 31, 2025, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025, and (vi) the Notes to the Condensed Consolidated Financial Statements. | |
104 | Cover page interactive data file, formatted in Inline XBRL and contained in Exhibit 101. |
KKR & CO. INC. | |||
By: | /s/ ROBERT H. LEWIN | ||
Robert H. Lewin | |||
Chief Financial Officer | |||
(principal financial and accounting officer) | |||
DATE: | May 8, 2026 | ||